<!-- This file corresponds to the Dose-Response Visualiser section of the page -->

<!DOCTYPE HTML>
<html lang="en">

<head>
	<meta charset="utf-8">
	<meta name="viewport" context="width=device-width, initial scale=1">
	<title>SPIKESfunc</title>

	<link rel="shortcut icon" href="images/favicon-196x196.png">
	<link rel="stylesheet" href="bootstrap/css/bootstrap.min.css">
	<link rel="stylesheet" href="css/button.css">
	<script src="plotly/plotly-latest.min.js"></script>
	<script src="bootstrap/js/jquery-3.3.1.min.js"></script>
	<link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/4.7.0/css/font-awesome.min.css">


	<!-- Add in plotly.js files still to go, might put them in body -->

	<link href="css/stylesheet.css" rel="stylesheet">

</head>

<body>
	<!-- This is the header section of the page -->
	<header>
		<nav class="navbar navbar-light navbar-expand-lg fixed-top header">
			<div class="container">
				<a class="navbar-brand nav-style" href="index.html">
					<img src="images/favicon-196x196.png" width="30" height="30" class="d-inline-block align-center"
						alt="">
					SPIKES<i>func</i></a>
				<button class="navbar-toggler" type="button" data-toggle="collapse" data-target="#navbarNavAltMarkup"
					aria-controls="navbarNavAltMarkup" aria-expanded="false" aria-label="Toggle navigation">
					<span class="navbar-toggler-icon"></span>
				</button>
				<div class="collapse navbar-collapse" id="navbarNavAltMarkup">
					<ul class="navbar-nav ml-auto">
						<li class="nav-item">
							<a class="nav-item nav-link nav-style active" href="qualitative.html">Dose-Response
								Visualiser</a>
						</li>
						<li class="nav-item">
							<a class="nav-item nav-link nav-style" href="quantitative.html">Schild Plot Generator</a>
						</li>
						<li class="nav-item">
							<a class="nav-item nav-link nav-style" href="quiz.html">Schild Plot Analysis Quiz</a>
						</li>
						<li class="nav-item">
							<a class="nav-item nav-link nav-style" href="logtable.html"
								target="_blank">-logK<sub>i</sub> Values</a>
						</li>
						<li class="nav-item">
							<a class="nav-item nav-link nav-style" href="video.html" target="_blank">Videos</a>
						</li>
						<li class="nav-item">
							<a class="nav-item nav-link nav-style" href="nonlinear.html">Non-Ideal Schild Plots</a>
						</li>
					</ul>
				</div>
			</div>
		</nav>
	</header>
	<div id="loader"></div>

	<!-- This is the navbar section of the page where it has the Agonist Competitve Antagonist etc.. section -->

	<div id="page" class="container box-size bg-box p-4" style="visibility: hidden; position: absolute;">
		<h1 class="d-flex justify-content-center">Dose-Response Visualiser</h1>
		<p style="text-align: center">
			<button class="btn waves-effect waves-light red" onclick="showInstructionsQual()"><span
					class="fa fa-info-circle"></span> What to do?</button>
		</p>
		<br>
		<!-- The list of 6 different -->
		<div class="container">
			<ul class="nav nav-pills nav-justified" role="tablist">
				<li class="nav-item">
					<a class="nav-link active" data-toggle="tab" href="#home">Agonist</br></a>
				</li>
				<li class="nav-item">
					<a class="nav-link" data-toggle="tab" href="#menu1">Competitive Antagonist</a>
				</li>
				<li class="nav-item">
					<a class="nav-link" data-toggle="tab" href="#menu2">Irreversible Antagonist</a>
				</li>
				<li class="nav-item">
					<a class="nav-link" data-toggle="tab" href="#menu3">Allosteric Antagonist (Affinity)</a>
				</li>
				<li class="nav-item">
					<a class="nav-link" data-toggle="tab" href="#menu4">Allosteric Antagonist (Efficacy)</a>
				</li>
				<li class="nav-item">
					<a class="nav-link" data-toggle="tab" href="#menu5">Functional Antagonist</a>
				</li>
				<li class="nav-item">
					<a class="nav-link" data-toggle="tab" href="#menu6">Inverse Agonist</a>
				</li>
			</ul>
		</div>

		<hr>
		<!-- This is the content below the visualisations -->

		<div class="tab-content">
			<div id="home" class="container tab-pane active">
				<div class="col col-lg-12">
					<div class="row">
						<div class="col-lg-5" style="padding-top:50px">
							<a data-toggle="modal" href="" data-target="#whattodo1"
								class="btn waves-effect waves-light red" role="button"><span
									class="fa fa-info-circle"></span>&nbspAgonist</a>
							<div id="whattodo1" class="modal fade" role="dialog">
								<div class="modal-dialog">
									<div class="modal-content">
										<!-- The AGONIST button -->
										<div class="modal-header">
											<h4 class="modal-title">Agonist</h4>
										</div>
										<div class="modal-body">
											<!-- The contents once Agonist button is clicked -->

											<div class="box">

												<p>Below is a short animation illustrating the action of agonists on
													receptors:</p>

												<div style='text-align:center'>
													<video width="320" height="240" controls>
														<source src="images/Agonist binding.mp4" type="video/mp4">
													</video>
												</div>
												<br>

												<p>A general schema of how agonists interact with receptors to produce a
													change in cellular activity is shown below.</p>
												<img src="images/agonistchart.png" alt="Agonist Chart"
													style="max-height: 100%; max-width: 100%;" /><br />
												<br>
												<p>Observe the effects of changing the characteristics of the Agonist
													(affinity, intrinsic efficacy) and/or the Cell (receptor density,
													signal amplification) by moving the red slider along the grey bar to
													the right or left to increase or decrease the value of the
													characteristic, respectively.</p>
												<p>Some clinically-used drugs act as agonists – e.g. salbutamol at the
													&#946<sub>2</sub>-adrenoceptor, adrenaline at various adrenoceptors,
													morphine at opioid receptors, etc.</p>

											</div>
										</div>
										<div class="modal-footer">
											<button type="button" class="btn waves-effect waves-light red"
												data-dismiss="modal">Close</button>
										</div>
									</div>
								</div>
							</div>
							<fieldset style="width: 430px;">
								<!-- This is all the content inside the Aginist box -->

								<legend>Agonist</legend>
								<label for="affinity">Affinity (&#8733 1/K<sub>A</sub>)&nbsp</label><a
									data-toggle="modal" href="" data-target="#info1"><i
										class="red1 fa fa-info-circle"></i></a>
								<div id="info1" class="modal fade" role="dialog">
									<div class="modal-dialog">
										<div class="modal-content">
											<div class="modal-header">
												<h4 class="modal-title">Affinity</h4>
											</div>
											<div class="modal-body">
												<div class="box">
													<p><b>Affinity</b> is a measure of the strength of binding of a drug
														to a receptor
														(both agonists and antagonists have affinity), and depends on
														the existence of chemical
														forces of attraction between the agonist and the receptor
														binding site (e.g. most
														commonly ionic bonds, hydrogen bonds, van der Waals forces). The
														strength of binding
														(affinity) depends upon the respective 3-D structures of the
														agonist and binding site –
														the strength of binding dissipates markedly as the distance
														between the agonist and
														binding site increases. High affinity agonists bind to binding
														sites at low concentrations,
														whereas low affinity agonists bind at higher concentrations. The
														affinity of ligands
														(agonists and antagonists) can be quantitated using the
														Equilibrium Dissociation
														Constant (K<sub>A</sub>), which is the concentration of ligand
														needed to occupy
														(bind to) 50% of receptors (in the absence of any competing
														ligands). K<sub>A</sub>
														is also the ratio of the rate the ligand (agonist or antagonist)
														leaves the receptor
														binding site (k<sub>off</sub>) and the rate it approaches the
														receptor binding site
														(k<sub>on</sub>). The K<sub>A</sub> value is inversely
														proportional to the affinity
														(high affinity ligands have low K<sub>A</sub> values, and vice
														versa) and is
														typically measured in drug binding assays (plots of [ligand]
														versus fractional
														receptor occupancy). As the [ligand] increases the fraction of
														receptor bound
														increases nonlinearly (rectangular hyperbolic function) to form
														a maximal asymptote
														(from which R<sub>T</sub> can be determined). Colloquially
														speaking, “affinity is
														what brings the drug to the receptor”.</p>

													<div style='text-align:center'>
														<video width="320" height="240" controls>
															<source
																src="images\[Ligand] and affinity on receptor binding.mp4"
																type="video/mp4">
														</video>
													</div>

												</div>
											</div>
											<div class="modal-footer">
												<button type="button" class="btn waves-effect waves-light red"
													data-dismiss="modal">Close</button>
											</div>
										</div>
									</div>
								</div>
								<input type="range" autocomplete="off" name="affinity" id="affslider" min="5" max="9"
									step="0.04" value="7" oninput="updateAffinity(this.value)">
								<br><label for="efficacy">Intrinsic Efficacy (&#949)&nbsp</label><a data-toggle="modal"
									href="" data-target="#info2"><i class="red1 fa fa-info-circle"></i></a>
								<div id="info2" class="modal fade" role="dialog">
									<div class="modal-dialog">
										<div class="modal-content">
											<div class="modal-header">
												<h4 class="modal-title">Intrinsic Efficacy</h4>
											</div>
											<div class="modal-body">
												<div class="box">

													<p><b>Intrinsic Efficacy</b> is the property of the agonist that
														enables it, once bound, to change the conformation of the
														receptor
														(activation), such that it alters the activity of downstream
														signaling
														pathways to produce a change in cellular activity. Efficacy is
														measured in
														relative terms, having no absolute scale – but different ligands
														have clearly
														different efficacies – full agonists have higher efficacies than
														partial agonists,
														and antagonists typically have no efficacy (bind to but don’t
														activate the receptor).
														Thus, different agonists have different inherent capacities to
														induce a response,
														and equal cellular responses can be achieved by different
														fractional receptor
														occupancies. Colloquially speaking, efficacy is “what the drug
														does once it
														binds to the receptor”.</p>

												</div>
											</div>
											<div class="modal-footer">
												<button type="button" class="btn waves-effect waves-light red"
													data-dismiss="modal">Close</button>
											</div>
										</div>
									</div>
								</div>
								<input type="range" autocomplete="off" name="efficacy" id="effslider" min="-0.7" max="0"
									step="0.01" value="-0.35" oninput="updateEfficacy(this.value)">
							</fieldset>
							<!-- The contents inside the Cell box -->

							<fieldset style="width: 430px;">
								<legend>Cell</legend>
								<label for="density">Receptor Density (R<sub>T</sub>)&nbsp</label><a data-toggle="modal"
									href="" data-target="#info3"><i class="red1 fa fa-info-circle"></i></a>
								<div id="info3" class="modal fade" role="dialog">
									<div class="modal-dialog">
										<div class="modal-content">
											<div class="modal-header">
												<h4 class="modal-title">Receptor Density</h4>
											</div>
											<div class="modal-body">
												<div class="box">
													<p><b>Receptor Density</b> is the total number of receptors,
														expressed in terms of unit area of membrane, or per cell, or per
														unit mass of protein. Proportional to the quantity
														B<sub>max</sub> (the maximal specific binding of a ligand, often
														expressed in units of mol ligand/mg protein, or ligands
														bound/cell) measured in radioligand binding studies. The
														relationship between B<sub>max</sub> and N is influenced by the
														number of ligand binding sites possessed by each receptor. For
														most receptors there is one binding site for the endogenous
														agonist, although for ligand-gated ion channels (e.g. nicotinic
														acetylcholine receptor), this is generally more than one.</p>
												</div>
											</div>
											<div class="modal-footer">
												<button type="button" class="btn waves-effect waves-light red"
													data-dismiss="modal">Close</button>
											</div>
										</div>
									</div>
								</div>

								<input type="range" autocomplete="off" name="density" id="denslider" min="-1" max="1"
									step="0.01" value="0" oninput="updateDensity(this.value)">
								<br><label for="efficiency">Signal Amplification (<i>&#947</i>)&nbsp</label><a
									data-toggle="modal" href="" data-target="#info4"><i
										class="red1 fa fa-info-circle"></i></a>

								<div id="info4" class="modal fade" role="dialog">
									<div class="modal-dialog">
										<div class="modal-content">
											<div class="modal-header">
												<h4 class="modal-title">Signal Amplification</h4>
												<!--Note: Coupling Efficacy has been replaced by Signal Amplification as per the new model. Variable names remain the same-->
											</div>
											<div class="modal-body">
												<div class="box">

													<p><b>Signal Amplification </b> is a cell-dependent parameter
														describing the efficiency of the signalling pathways that
														couple (link) the activated receptor to the measured effect.
														Some cells have high signal amplification capacities, meaning
														that activation of a relatively small number of receptors can
														lead to a large cellular response. Other cells may have low
														signal amplification capacities (perhaps due to low
														expression / activity of a key signalling pathway component)
														and high levels of receptor activation may produce relatively
														small cellular responses.</p>

												</div>
											</div>
											<div class="modal-footer">
												<button type="button" class="btn waves-effect waves-light red"
													data-dismiss="modal">Close</button>
											</div>
										</div>
									</div>
								</div>
								<input type="range" autocomplete="off" name="efficiency" id="efficislider" min="0"
									max="2" step="0.01" value="1" oninput="updateEfficiency(this.value)">
							</fieldset>
							<!-- The contents inside the quiz box -->

							<fieldset style="width:450px;text-align:center">
								<legend>Questions</legend>
								<div id="agonistQuestion" style="margin-bottom:20px;"></div>
								<div id="restartMessageAgonist" style="display:none">There are no more questions. Would
									you like to try again?<br><br></div>

								<div id="agonistAnswerModal" class="modal fade" role="dialog">
									<div class="modal-dialog">
										<div class="modal-content">
											<div class="modal-header">
												<h4 class="modal-title">Answer</h4>
											</div>
											<div class="modal-body">
												<div class="box">
													<div id="agonistAnswer"></div>
												</div>
											</div>
											<div class="modal-footer">
												<button type="button" class="btn waves-effect waves-light red"
													data-dismiss="modal">Close</button>
											</div>
										</div>
									</div>
								</div>

								<button id="restartQuestionAgonist" style="display:none" type="button"
									class="btn waves-effect waves-light red qbutton"
									onclick="restartQuestionAgonist()">Restart</button>
								<button id="prevAgonistQuestion" style="float:left" type="button"
									class="btn waves-effect waves-light red qbutton"
									onclick="prevQuestionAgonist()">Previous Question</button>
								<button id="revealAgonistAnswer" type="button"
									class="btn waves-effect waves-light red qbutton"
									onclick="revealAnswerAgonist()">Reveal Answer</button>
								<button id="nextAgonistQuestion" style="float:right" type="button"
									class="btn waves-effect waves-light red qbutton"
									onclick="nextQuestionAgonist()">Next Question</button>

							</fieldset>

						</div>
						<!-- The Agonist box -->

						<div class="col-lg-7">
							<fieldset style="display:block">
								<legend>Agonist Dose Response Curve</legend>
								<h5 class="warning" id="agoalert"></h5>
								<div id="agonist"></div>
							</fieldset>
							<button id="reset" type="button" class="btn waves-effect waves-light red"
								onclick="resetAgo()" style="float: right;">Reset</button>
						</div>
					</div>
				</div>
			</div>
			<!-- This section relates to the Competitive Antagonist section -->

			<div id="menu1" class="container tab-pane fade">
				<div class="col col-lg-12">
					<div class="row">
						<div class="col-lg-5" style="padding-top: 50px;">
							<a data-toggle="modal" href="" data-target="#whattodo2"
								class="btn waves-effect waves-light red" role="button"><span
									class="fa fa-info-circle"></span>&nbspCompetitive Antagonist</a>
							<div id="whattodo2" class="modal fade" role="dialog">
								<div class="modal-dialog">
									<div class="modal-content">
										<div class="modal-header">
											<h4 class="modal-title">Competitive Antagonist</h4>
										</div>
										<div class="modal-body">
											<div class="box">

												<p>Competitive antagonists bind reversibly to the same binding site on
													the receptor as the agonist (orthosteric binding).

												<div style='text-align:center'>
													<video width="320" height="240" controls>
														<source src="images/Competitive Receptor Antagonist.mp4"
															type="video/mp4">
													</video>
												</div>
												<br>

												Thus, which molecule occupies the common binding site depends solely on
												the relative affinity and concentrations of the agonist and competitive
												antagonist.

												<div style='text-align:center'>
													<video width="320" height="240" controls>
														<source src="images/Comp. Antagonists - cellular effect.mp4"
															type="video/mp4">
													</video>
												</div>
												<br>

												Thus, theoretically the [agonist] can be raised to the point that the
												concomitant receptor binding by the antagonist is minimal – at this
												point the maximum effect of the agonist will be observed, that is
												competitive antagonism is surmountable.

												<div style='text-align:center'>
													<video width="320" height="240" controls>
														<source src="images/Comp. Antagonist - agonist DR effect.mp4"
															type="video/mp4">
													</video>
												</div>
												<br>

												The affinity of a competitive antagonist for a receptor can be
												determined from <b>binding</b> assays (saturation (K<sub>A</sub>) and/or
												competition binding (K<sub>i</sub>) assays using radioligands) and from
												<b>functional</b> assays (K<sub>B</sub>, by measuring the rightward
												shift of agonist dose-response curves in the presence of increasing
												[competitive antagonist] – Schild analysis). Although the constants
												<b>K<sub>A</sub>, K<sub>i</sub> and K<sub>B</sub></b> are determined
												using different experimental approaches, they each represent the
												affinity of the competitive antagonist for a receptor, and thus should
												have the <b>same molar value</b> (the concentration required to occupy
												50% of receptors).
												</p>

												<img src="images/competitivechart.png" alt="Competitive Chart"
													style="max-height: 100%; max-width: 100%;" /><br />
												<p>The vast majority of clinically-used receptor antagonists are
													considered to act competitively – e.g. metoprolol at the
													&#946-adrenoceptor, atropine at the muscarinic cholinoceptor,
													losartan at the angiotensin AT1 receptor, etc.</p>

											</div>
										</div>
										<div class="modal-footer">
											<button type="button" class="btn waves-effect waves-light red"
												data-dismiss="modal">Close</button>
										</div>
									</div>
								</div>
							</div>
							<fieldset style="width: 430px;">
								<legend>Agonist</legend>
								<label for="affinity">Affinity (&#8733 1/K<sub>A</sub>)&nbsp</label><a
									data-toggle="modal" href="" data-target="#info5"><i
										class="red1 fa fa-info-circle"></i></a>
								<div id="info5" class="modal fade" role="dialog">
									<div class="modal-dialog">
										<div class="modal-content">
											<div class="modal-header">
												<h4 class="modal-title">Affinity</h4>
											</div>
											<div class="modal-body">
												<div class="box">
													<p><b>Affinity</b> is a measure of the strength of binding of a drug
														to a receptor
														(both agonists and antagonists have affinity), and depends on
														the existence of chemical
														forces of attraction between the agonist and the receptor
														binding site (e.g. most
														commonly ionic bonds, hydrogen bonds, van der Waals forces). The
														strength of binding
														(affinity) depends upon the respective 3-D structures of the
														agonist and binding site –
														the strength of binding dissipates markedly as the distance
														between the agonist and
														binding site increases. High affinity agonists bind to binding
														sites at low concentrations,
														whereas low affinity agonists bind at higher concentrations. The
														affinity of ligands
														(agonists and antagonists) can be quantitated using the
														Equilibrium Dissociation
														Constant (K<sub>A</sub>), which is the concentration of ligand
														needed to occupy
														(bind to) 50% of receptors (in the absence of any competing
														ligands). K<sub>A</sub>
														is also the ratio of the rate the ligand (agonist or antagonist)
														leaves the receptor
														binding site (k<sub>off</sub>) and the rate it approaches the
														receptor binding site
														(k<sub>on</sub>). The K<sub>A</sub> value is inversely
														proportional to the affinity
														(high affinity ligands have low K<sub>A</sub> values, and vice
														versa) and is
														typically measured in drug binding assays (plots of [ligand]
														versus fractional
														receptor occupancy). As the [ligand] increases the fraction of
														receptor bound
														increases nonlinearly (rectangular hyperbolic function) to form
														a maximal asymptote
														(from which R<sub>T</sub> can be determined). Colloquially
														speaking, “affinity is
														what brings the drug to the receptor”.</p>

													<div style='text-align:center'>
														<video width="320" height="240" controls>
															<source
																src="images\[Ligand] and affinity on receptor binding.mp4"
																type="video/mp4">
														</video>
													</div>
												</div>
											</div>
											<div class="modal-footer">
												<button type="button" class="btn waves-effect waves-light red"
													data-dismiss="modal">Close</button>
											</div>
										</div>
									</div>
								</div>
								<input type="range" autocomplete="off" name="affinity" id="affcomslider" min="5" max="9"
									step="0.04" value="7" oninput="updateAffinityCom(this.value)">
								<br><label for="efficacy">Intrinsic Efficacy (&#949)&nbsp</label><a data-toggle="modal"
									href="" data-target="#info6"><i class="red1 fa fa-info-circle"></i></a>
								<div id="info6" class="modal fade" role="dialog">
									<div class="modal-dialog">
										<div class="modal-content">
											<div class="modal-header">
												<h4 class="modal-title">Intrinsic Efficacy</h4>
											</div>
											<div class="modal-body">
												<div class="box">
													<p><b>Intrinsic Efficacy</b> is the property of the agonist that
														enables it, once bound, to change the conformation of the
														receptor (activation), such that it alters the activity of
														downstream signalling pathways to produce a change in cellular
														activity. Efficacy is measured in relative terms, having no
														absolute scale – but different ligands have clearly different
														efficacies – full agonists have higher efficacies than partial
														agonists, and antagonists typically have no efficacy (bind to
														but don’t activate the receptor). Thus, different agonists have
														different inherent capacities to induce a response, and equal
														cellular responses can be achieved by different fractional
														receptor occupancies. Colloquially, efficacy is “what the drug
														does once it binds to the receptor”.</p>
												</div>
											</div>
											<div class="modal-footer">
												<button type="button" class="btn waves-effect waves-light red"
													data-dismiss="modal">Close</button>
											</div>
										</div>
									</div>
								</div>
								<input type="range" autocomplete="off" name="efficacy" id="effcomslider" min="-0.7"
									max="0" step="0.01" value="-0.35" oninput="updateEfficacyCom(this.value)">
							</fieldset>
							<fieldset style="width: 430px;">
								<legend>Cell</legend>
								<label for="density">Receptor Density (R<sub>T</sub>)&nbsp</label><a data-toggle="modal"
									href="" data-target="#info7"><i class="red1 fa fa-info-circle"></i></a>
								<div id="info7" class="modal fade" role="dialog">
									<div class="modal-dialog">
										<div class="modal-content">
											<div class="modal-header">
												<h4 class="modal-title">Receptor Density</h4>
											</div>
											<div class="modal-body">
												<div class="box">
													<p><b>Receptor Density</b> is the total number of receptors,
														expressed in terms of unit area of membrane, or per cell, or per
														unit mass of protein. Proportional to the quantity
														B<sub>max</sub> (the maximal specific binding of a ligand, often
														expressed in units of mol ligand/mg protein, or ligands
														bound/cell) measured in radioligand binding studies. The
														relationship between B<sub>max</sub> and N is influenced by the
														number of ligand binding sites possessed by each receptor. For
														most receptors there is one binding site for the endogenous
														agonist, although for ligand-gated ion channels (e.g. nicotinic
														acetylcholine receptor), this is generally more than one.</p>
												</div>
											</div>
											<div class="modal-footer">
												<button type="button" class="btn waves-effect waves-light red"
													data-dismiss="modal">Close</button>
											</div>
										</div>
									</div>
								</div>

								<input type="range" autocomplete="off" name="density" id="dencomslider" min="-1" max="1"
									step="0.01" value="0" oninput="updateDensityCom(this.value)">
								<br><label for="efficiency">Signal Amplification (<i>&#947</i>)&nbsp</label><a
									data-toggle="modal" href="" data-target="#info8"><i
										class="red1 fa fa-info-circle"></i></a>

								<div id="info8" class="modal fade" role="dialog">
									<div class="modal-dialog">
										<div class="modal-content">
											<div class="modal-header">
												<h4 class="modal-title">Signal Amplification</h4>
											</div>
											<div class="modal-body">
												<div class="box">

													<p><b>Signal Amplification</b> is a cell-dependent parameter
														describing
														the efficiency of the signalling pathways that couple (link)
														the activated receptor to the measured effect. Some cells have
														high coupling efficiencies, meaning that activation of a
														relatively
														small number of receptors can lead to a large cellular response.
														Other cells may have low coupling efficiencies (perhaps due to
														low
														expression / activity of a key signalling pathway component) and
														high levels of receptor activation may produce relatively small
														cellular responses.</p>

												</div>
											</div>
											<div class="modal-footer">
												<button type="button" class="btn waves-effect waves-light red"
													data-dismiss="modal">Close</button>
											</div>
										</div>
									</div>
								</div>
								<input type="range" autocomplete="off" name="efficiency" id="efficicomslider" min="0"
									max="2" step="0.01" value="1" oninput="updateEfficiencyCom(this.value)">
							</fieldset>
							<fieldset style="width: 430px;">
								<legend>Competitive Antagonist</legend>
								<label for="agoaffinity">Affinity (&#8733 1/K<sub>B</sub>)&nbsp</label>

								<!-- COMPETATIVE ANAGONIST 1/KB SLIDER -->

								<input type="range" autocomplete="off" name="agoaffinity" id="agoaffcomslider" min="7"
									max="11" step="0.04" value="9" oninput="updateAgoAffinityCom(this.value)"><br />
								<label for="antagocomp">-logK<sub>B</sub> =&nbsp</label>
								<input class="numbox" type="number" autocomplete="off" name="antagocomp" id="antagocomp"
									style="width: 60px;" readonly>
							</fieldset>

							<!--COLOURS OF DIFFERENT ONES-->
							<fieldset style="width:450px;text-align:center">
								<legend>Questions</legend>
								<div id="comQuestion" style="margin-bottom:20px;"></div>
								<div id="restartMessageCom" style="display:none">There are no more questions. Would you
									like to try again?<br><br></div>


								<div id="comAnswerModal" class="modal fade" role="dialog">
									<div class="modal-dialog">
										<div class="modal-content">
											<div class="modal-header">
												<h4 class="modal-title">Answer</h4>
											</div>
											<div class="modal-body">
												<div class="box">
													<div id="comAnswer"></div>
												</div>
											</div>
											<div class="modal-footer">
												<button type="button" class="btn waves-effect waves-light red"
													data-dismiss="modal">Close</button>
											</div>
										</div>
									</div>
								</div>

								<button id="restartQuestionCom" style="display:none" type="button"
									class="btn waves-effect waves-light red qbutton"
									onclick="restartQuestionCom()">Restart</button>
								<button id="prevComQuestion" style="float:left" type="button"
									class="btn waves-effect waves-light red qbutton"
									onclick="prevQuestionCom()">Previous Question</button>
								<button id="revealComAnswer" type="button"
									class="btn waves-effect waves-light red qbutton" onclick="revealAnswerCom()">Reveal
									Answer</button>
								<button id="nextComQuestion" style="float:right" type="button"
									class="btn waves-effect waves-light red qbutton" onclick="nextQuestionCom()">Next
									Question</button>
							</fieldset>

						</div>
						<div class="col-lg-7">
							<fieldset>
								<legend>Effect of a Competitive Antagonist on Agonist Dose Response Curve</legend>
								<h5 class="warning" id="comalert"></h5>
								<div id="competitive"></div>
							</fieldset>
							<button id="reset" type="button" class="btn waves-effect waves-light red"
								onclick="resetCom()" style="float: right;">Reset</button>

							<!-- NEW - ALLOW CHANGING OF nM Values-->

							<fieldset style="width: 430px;">
								<legend>Antagonist Concentration (M)</legend>
								<label>[Antagonist] #1 : 1.0e</label>
								<input class="numbox" type="number" autocomplete="off" id="comline2" min="-12" max="0"
									style="width: 100px; background-color: yellow;" value="-9" step="0.1"
									oninput="updateConcentrationCom(this.value, 1)"></br>

								<label>[Antagonist] #2 : 1.0e</label>
								<input class="numbox" type="number" autocomplete="off" id="comline3" min="-12" max="0"
									style="width: 100px; background-color: rgb(13, 228, 13);" value="-8" step="0.1"
									oninput="updateConcentrationCom(this.value, 2)"></br>

								<label>[Antagonist] #3 : 1.0e</label>
								<input class="numbox" type="number" autocomplete="off" id="comline4" min="-12" max="0"
									style="width: 100px; background-color: red;" value="-7" step="0.1"
									oninput="updateConcentrationCom(this.value, 3)"></br>

								<label>[Antagonist] #4 : 1.0e</label>
								<input class="numbox" type="number" autocomplete="off" id="comline5" min="-12" max="0"
									style="width: 100px; background-color: #4D8BFF;" value="-6" step="0.1"
									oninput="updateConcentrationCom(this.value, 4)"></br>
							</fieldset>
						</div>
					</div>
				</div>
			</div>
			<!-- This section relates to the Irreversible Antagonist -->

			<div id="menu2" class="container tab-pane fade">
				<div class="col col-lg-12">
					<div class="row">
						<div class="col-lg-5" style="padding-top: 50px;">
							<a data-toggle="modal" href="" data-target="#whattodo3"
								class="btn waves-effect waves-light red" role="button"><span
									class="fa fa-info-circle"></span>&nbspIrreversible Antagonist</a>
							<div id="whattodo3" class="modal fade" role="dialog">
								<div class="modal-dialog">
									<div class="modal-content">
										<div class="modal-header">
											<h4 class="modal-title">Irreversible Antagonist</h4>
										</div>
										<div class="modal-body">
											<div class="box">

												<p>An irreversible antagonist binds <b>covalently</b> (not reversibly)
													to the same binding site on the receptor as the agonist (orthosteric
													binding), without activating the receptor.

												<div style='text-align:center'>
													<video width="320" height="240" controls>
														<source src="images\Irreversible Receptor antagonist.mp4"
															type="video/mp4">
													</video>
												</div>
												<br>

												Such antagonists irreversibly inhibit agonist-induced responses, until
												new functional receptors are expressed by the cell. Irreversible
												antagonism is one form of non-competitive antagonism.

												<div style='text-align:center'>
													<video width="320" height="240" controls>
														<source src="images\Irrev. Antagonist - cellular effect.mp4"
															type="video/mp4">
													</video>
												</div>
												<br>

												<p>Irreversible antagonists have profound effects on both the position
													and shape of the agonist dose-response curve, as can be seen in the
													following video, and by using the Dose-Response Visualiser.</p>
												<div style='text-align:center'>
													<video width="320" height="240" controls>
														<source src="images\Irrev. Antagonist - agonist DR effect.mp4"
															type="video/mp4">
													</video>
												</div>
												<br>

												<img src="images/irreversiblechart.png" alt="Irreversible Chart"
													style="max-height: 100%; max-width: 100%;" />
												<br>
												<p>Relatively few clinically-used receptor antagonists are considered to
													act irreversibly – e.g. naloxazone at the opioid mu receptor,
													phenoxybenzamine at the &#945 adrenoceptor. Some drugs act
													‘pseudoirreversibly’ and occupy the orthosteric binding site for
													relatively long periods without forming a covalent bond e.g.
													tiotropium at the muscarinic cholinoceptor.</p>


											</div>
										</div>
										<div class="modal-footer">
											<button type="button" class="btn waves-effect waves-light red"
												data-dismiss="modal">Close</button>
										</div>
									</div>
								</div>
							</div>
							<fieldset style="width: 430px;">
								<legend>Agonist</legend>
								<label for="affinity">Affinity (&#8733 1/K<sub>A</sub>)&nbsp</label><a
									data-toggle="modal" href="" data-target="#info9"><i
										class="red1 fa fa-info-circle"></i></a>
								<div id="info9" class="modal fade" role="dialog">
									<div class="modal-dialog">
										<div class="modal-content">
											<div class="modal-header">
												<h4 class="modal-title">Affinity</h4>
											</div>
											<div class="modal-body">
												<div class="box">
													<p><b>Affinity</b> is a measure of the strength of binding of a drug
														to a receptor
														(both agonists and antagonists have affinity), and depends on
														the existence of chemical
														forces of attraction between the agonist and the receptor
														binding site (e.g. most
														commonly ionic bonds, hydrogen bonds, van der Waals forces). The
														strength of binding
														(affinity) depends upon the respective 3-D structures of the
														agonist and binding site –
														the strength of binding dissipates markedly as the distance
														between the agonist and
														binding site increases. High affinity agonists bind to binding
														sites at low concentrations,
														whereas low affinity agonists bind at higher concentrations. The
														affinity of ligands
														(agonists and antagonists) can be quantitated using the
														Equilibrium Dissociation
														Constant (K<sub>A</sub>), which is the concentration of ligand
														needed to occupy
														(bind to) 50% of receptors (in the absence of any competing
														ligands). K<sub>A</sub>
														is also the ratio of the rate the ligand (agonist or antagonist)
														leaves the receptor
														binding site (k<sub>off</sub>) and the rate it approaches the
														receptor binding site
														(k<sub>on</sub>). The K<sub>A</sub> value is inversely
														proportional to the affinity
														(high affinity ligands have low K<sub>A</sub> values, and vice
														versa) and is
														typically measured in drug binding assays (plots of [ligand]
														versus fractional
														receptor occupancy). As the [ligand] increases the fraction of
														receptor bound
														increases nonlinearly (rectangular hyperbolic function) to form
														a maximal asymptote
														(from which R<sub>T</sub> can be determined). Colloquially
														speaking, “affinity is
														what brings the drug to the receptor”.</p>

													<div style='text-align:center'>
														<video width="320" height="240" controls>
															<source
																src="images\[Ligand] and affinity on receptor binding.mp4"
																type="video/mp4">
														</video>
													</div>
												</div>
											</div>
											<div class="modal-footer">
												<button type="button" class="btn waves-effect waves-light red"
													data-dismiss="modal">Close</button>
											</div>
										</div>
									</div>
								</div>
								<input type="range" autocomplete="off" name="affinity" id="affirrslider" min="5" max="9"
									step="0.04" value="7" oninput="updateAffinityIrr(this.value)">
								<br><label for="efficacy">Intrinsic Efficacy (&#949)&nbsp</label><a data-toggle="modal"
									href="" data-target="#info10"><i class="red1 fa fa-info-circle"></i></a>
								<div id="info10" class="modal fade" role="dialog">
									<div class="modal-dialog">
										<div class="modal-content">
											<div class="modal-header">
												<h4 class="modal-title">Intrinsic Efficacy</h4>
											</div>
											<div class="modal-body">
												<div class="box">
													<p><b>Intrinsic Efficacy</b> is the property of the agonist that
														enables it, once bound, to change the conformation of the
														receptor (activation), such that it alters the activity of
														downstream signalling pathways to produce a change in cellular
														activity. Efficacy is measured in relative terms, having no
														absolute scale – but different ligands have clearly different
														efficacies – full agonists have higher efficacies than partial
														agonists, and antagonists typically have no efficacy (bind to
														but don’t activate the receptor). Thus, different agonists have
														different inherent capacities to induce a response, and equal
														cellular responses can be achieved by different fractional
														receptor occupancies. Colloquially, efficacy is “what the drug
														does once it binds to the receptor”.</p>
												</div>
											</div>
											<div class="modal-footer">
												<button type="button" class="btn waves-effect waves-light red"
													data-dismiss="modal">Close</button>
											</div>
										</div>
									</div>
								</div>
								<input type="range" autocomplete="off" name="efficacy" id="effirrslider" min="-0.7"
									max="0" step="0.01" value="-0.35" oninput="updateEfficacyIrr(this.value)">
							</fieldset>
							<fieldset style="width: 430px;">
								<legend>Cell</legend>
								<label for="density">Receptor Density (R<sub>T</sub>)&nbsp</label><a data-toggle="modal"
									href="" data-target="#info11"><i class="red1 fa fa-info-circle"></i></a>
								<div id="info11" class="modal fade" role="dialog">
									<div class="modal-dialog">
										<div class="modal-content">
											<div class="modal-header">
												<h4 class="modal-title">Receptor Density</h4>
											</div>
											<div class="modal-body">
												<div class="box">
													<p><b>Receptor Density</b> is the total number of receptors,
														expressed in terms of unit area of membrane, or per cell, or per
														unit mass of protein. Proportional to the quantity
														B<sub>max</sub> (the maximal specific binding of a ligand, often
														expressed in units of mol ligand/mg protein, or ligands
														bound/cell) measured in radioligand binding studies. The
														relationship between B<sub>max</sub> and N is influenced by the
														number of ligand binding sites possessed by each receptor. For
														most receptors there is one binding site for the endogenous
														agonist, although for ligand-gated ion channels (e.g. nicotinic
														acetylcholine receptor), this is generally more than one.</p>
												</div>
											</div>
											<div class="modal-footer">
												<button type="button" class="btn waves-effect waves-light red"
													data-dismiss="modal">Close</button>
											</div>
										</div>
									</div>
								</div>

								<input type="range" autocomplete="off" name="density" id="denirrslider" min="-1" max="1"
									step="0.01" value="0" oninput="updateDensityIrr(this.value)">
								<br><label for="efficiency">Signal Amplification (<i>&#947</i>)&nbsp</label><a
									data-toggle="modal" href="" data-target="#info12"><i
										class="red1 fa fa-info-circle"></i></a>

								<div id="info12" class="modal fade" role="dialog">
									<div class="modal-dialog">
										<div class="modal-content">
											<div class="modal-header">
												<h4 class="modal-title">Signal Amplification</h4>
											</div>
											<div class="modal-body">
												<div class="box">

													<p><b>Signal Amplification</b> is a cell-dependent parameter
														describing the efficiency of the signalling pathways that
														couple (link) the activated receptor to the measured effect.
														Some cells have high coupling efficiencies, meaning that
														activation of a relatively small number of receptors can
														lead to a large cellular response. Other cells may have low
														coupling efficiencies (perhaps due to low expression / activity
														of a key signalling pathway component) and high levels of
														receptor activation may produce relatively small cellular
														responses.</p>


												</div>
											</div>
											<div class="modal-footer">
												<button type="button" class="btn waves-effect waves-light red"
													data-dismiss="modal">Close</button>
											</div>
										</div>
									</div>
								</div>
								<input type="range" autocomplete="off" name="efficiency" id="efficiirrslider" min="0"
									max="2" step="0.01" value="1" oninput="updateEfficiencyIrr(this.value)">
							</fieldset>
							<fieldset style="width: 430px;">
								<legend>Irreversible Antagonist</legend>
								<label for="agoaffinity">Affinity (&#8733 1/K<sub>B</sub>)&nbsp</label>
								<input type="range" autocomplete="off" name="agoaffinity" id="agoaffirrslider" min="7"
									max="11" step="0.04" value="9" oninput="updateAgoAffinityIrr(this.value)"><br />
								<label for="antagoirr">-logK<sub>B</sub> =&nbsp</label>
								<input class="numbox" type="number" autocomplete="off" name="antagoirr" id="antagoirr"
									style="width: 60px;" readonly>
							</fieldset>
							<fieldset style="width:450px; text-align:center">
								<legend>Questions</legend>
								<div id="irrQuestion" style="margin-bottom:20px;"></div>
								<div id="restartMessageIrr" style="display:none">There are no more questions. Would you
									like to try again?<br><br></div>


								<div id="irrAnswerModal" class="modal fade" role="dialog">
									<div class="modal-dialog">
										<div class="modal-content">
											<div class="modal-header">
												<h4 class="modal-title">Answer</h4>
											</div>
											<div class="modal-body">
												<div class="box">
													<div id="irrAnswer"></div>
												</div>
											</div>
											<div class="modal-footer">
												<button type="button" class="btn waves-effect waves-light red"
													data-dismiss="modal">Close</button>
											</div>
										</div>
									</div>
								</div>

								<button id="restartQuestionIrr" style="display:none" type="button"
									class="btn waves-effect waves-light red qbutton"
									onclick="restartQuestionIrr()">Restart</button>
								<button id="prevIrrQuestion" style="float:left" type="button"
									class="btn waves-effect waves-light red qbutton"
									onclick="prevQuestionIrr()">Previous Question</button>
								<button id="revealIrrAnswer" type="button"
									class="btn waves-effect waves-light red qbutton" onclick="revealAnswerIrr()">Reveal
									Answer</button>
								<button id="nextIrrQuestion" style="float:right" type="button"
									class="btn waves-effect waves-light red qbutton" onclick="nextQuestionIrr()">Next
									Question</button>
							</fieldset>
						</div>
						<div class="col-lg-7">
							<fieldset>
								<legend>Effect of an Irreversible Antagonist on Agonist Dose Response Curve</legend>
								<h5 class="warning" id="irralert"></h5>
								<div id="irreversible"></div>
							</fieldset>
							<button id="reset" type="button" class="btn waves-effect waves-light red"
								onclick="resetIrr()" style="float: right;">Reset</button>

							<!-- NEW - ALLOW CHANGING OF nM Values-->

							<fieldset style="width: 430px;">
								<legend>Antagonist Concentration (M)</legend>
								<label>[Antagonist] #1 : 1.0e</label>
								<input class="numbox" type="number" autocomplete="off" id="irrline2" min="-12" max="0"
									style="width: 100px; background-color: yellow;" value="-9" step="0.1"
									oninput="updateConcentrationIrr(this.value, 1)"></br>

								<label>[Antagonist] #2 : 1.0e</label>
								<input class="numbox" type="number" autocomplete="off" id="irrline3" min="-12" max="0"
									style="width: 100px; background-color: rgb(13, 228, 13);" value="-8" step="0.1"
									oninput="updateConcentrationIrr(this.value, 2)"></br>

								<label>[Antagonist] #3 : 1.0e</label>
								<input class="numbox" type="number" autocomplete="off" id="irrline4" min="-12" max="0"
									style="width: 100px; background-color: red;" value="-7" step="0.1"
									oninput="updateConcentrationIrr(this.value, 3)"></br>

								<label>[Antagonist] #4 : 1.0e</label>
								<input class="numbox" type="number" autocomplete="off" id="irrline5" min="-12" max="0"
									style="width: 100px; background-color: #4D8BFF;" value="-6" step="0.1"
									oninput="updateConcentrationIrr(this.value, 4)"></br>
							</fieldset>
						</div>
					</div>
				</div>
			</div>
			<!-- This section relates to Allosteric Antagonist -->

			<div id="menu3" class="container tab-pane fade">
				<div class="col col-lg-12">
					<div class="row">
						<div class="col-lg-5" style="padding-top: 50px;">
							<a data-toggle="modal" href="" data-target="#whattodo4"
								class="btn waves-effect waves-light red" role="button"><span
									class="fa fa-info-circle"></span>&nbspAllosteric Antagonist</a>
							<div id="whattodo4" class="modal fade" role="dialog">
								<div class="modal-dialog">
									<div class="modal-content">
										<div class="modal-header">
											<h4 class="modal-title">Allosteric Antagonist (Affinity)</h4>
										</div>
										<div class="modal-body">
											<div class="box">

												<p>Allosteric antagonists bind reversibly to receptors, without
													activating the receptor, at a site that is <b>different</b> from the
													agonist binding site.

												<div style='text-align:center'>
													<video width="320" height="240" controls>
														<source src="images/Allosteric Receptor Antagonist affinity.mp4"
															type="video/mp4">
													</video>
												</div>
												<br>

												Some allosteric antagonists reduce agonist affinity (without affecting
												efficacy), thereby inhibiting agonist-induced effects. They are also
												referred to as negative allosteric modulators (NAMs). Unlike competitive
												antagonists, the effects of an allosteric antagonist are saturable –
												this is because once the allosteric site is saturated, there are no
												further allosteric effects on the agonist.

												<div style='text-align:center'>
													<video width="320" height="240" controls>
														<source
															src="images/Allosteric Antag. affinity - cellular effect.mp4"
															type="video/mp4">
													</video>
												</div>
												<br>

												<p>Allosteric antagonists have unique effects on the position of the
													agonist dose-response curve, as can be seen in the following video,
													and by using the Dose-Response Visualiser.</p>

												<div style='text-align:center'>
													<video width="320" height="240" controls>
														<source
															src="images\Allosteric Antag. affinity - agonist DR effect.mp4"
															type="video/mp4">
													</video>
												</div>
												<br>

												Allosteric antagonism is another form of non-competitive antagonism, as
												a receptor can bind both the agonist and the allosteric antagonist
												simultaneously.</p>
												<img src="images/allostericchart.png" alt="Affinity Chart"
													style="max-height: 100%; max-width: 100%;" /><br />
												<br>
												<p>Relatively few clinically-used receptor antagonists are considered to
													act as negative allosteric modulators although this is an active
													area of research, e.g. maraviroc at the CCR5 receptor is an
													allosteric antagonist. In contrast, drugs such as the
													benzodiazepines act as positive allosteric modulators and enhance
													the binding affinity of the agonist</p>

											</div>
										</div>
										<div class="modal-footer">
											<button type="button" class="btn waves-effect waves-light red"
												data-dismiss="modal">Close</button>
										</div>
									</div>
								</div>
							</div>
							<fieldset style="width: 430px;">
								<legend>Agonist</legend>
								<label for="affinity">Affinity (&#8733 1/K<sub>A</sub>)&nbsp</label><a
									data-toggle="modal" href="" data-target="#info13"><i
										class="red1 fa fa-info-circle"></i></a>
								<div id="info13" class="modal fade" role="dialog">
									<div class="modal-dialog">
										<div class="modal-content">
											<div class="modal-header">
												<h4 class="modal-title">Affinity</h4>
											</div>
											<div class="modal-body">
												<div class="box">
													<p><b>Affinity</b> is a measure of the strength of binding of a drug
														to a receptor
														(both agonists and antagonists have affinity), and depends on
														the existence of chemical
														forces of attraction between the agonist and the receptor
														binding site (e.g. most
														commonly ionic bonds, hydrogen bonds, van der Waals forces). The
														strength of binding
														(affinity) depends upon the respective 3-D structures of the
														agonist and binding site –
														the strength of binding dissipates markedly as the distance
														between the agonist and
														binding site increases. High affinity agonists bind to binding
														sites at low concentrations,
														whereas low affinity agonists bind at higher concentrations. The
														affinity of ligands
														(agonists and antagonists) can be quantitated using the
														Equilibrium Dissociation
														Constant (K<sub>A</sub>), which is the concentration of ligand
														needed to occupy
														(bind to) 50% of receptors (in the absence of any competing
														ligands). K<sub>A</sub>
														is also the ratio of the rate the ligand (agonist or antagonist)
														leaves the receptor
														binding site (k<sub>off</sub>) and the rate it approaches the
														receptor binding site
														(k<sub>on</sub>). The K<sub>A</sub> value is inversely
														proportional to the affinity
														(high affinity ligands have low K<sub>A</sub> values, and vice
														versa) and is
														typically measured in drug binding assays (plots of [ligand]
														versus fractional
														receptor occupancy). As the [ligand] increases the fraction of
														receptor bound
														increases nonlinearly (rectangular hyperbolic function) to form
														a maximal asymptote
														(from which R<sub>T</sub> can be determined). Colloquially
														speaking, “affinity is
														what brings the drug to the receptor”.</p>

													<div style='text-align:center'>
														<video width="320" height="240" controls>
															<source
																src="images\[Ligand] and affinity on receptor binding.mp4"
																type="video/mp4">
														</video>
													</div>
												</div>
											</div>
											<div class="modal-footer">
												<button type="button" class="btn waves-effect waves-light red"
													data-dismiss="modal">Close</button>
											</div>
										</div>
									</div>
								</div>
								<input type="range" autocomplete="off" name="affinity" id="affaffslider" min="5" max="9"
									step="0.04" value="7" oninput="updateAffinityAff(this.value)">
								<br><label for="efficacy">Intrinsic Efficacy (&#949)&nbsp</label><a data-toggle="modal"
									href="" data-target="#info14"><i class="red1 fa fa-info-circle"></i></a>
								<div id="info14" class="modal fade" role="dialog">
									<div class="modal-dialog">
										<div class="modal-content">
											<div class="modal-header">
												<h4 class="modal-title">Intrinsic Efficacy</h4>
											</div>
											<div class="modal-body">
												<div class="box">
													<p><b>Intrinsic Efficacy</b> is the property of the agonist that
														enables it, once bound, to change the conformation of the
														receptor (activation), such that it alters the activity of
														downstream signalling pathways to produce a change in cellular
														activity. Efficacy is measured in relative terms, having no
														absolute scale – but different ligands have clearly different
														efficacies – full agonists have higher efficacies than partial
														agonists, and antagonists typically have no efficacy (bind to
														but don’t activate the receptor). Thus, different agonists have
														different inherent capacities to induce a response, and equal
														cellular responses can be achieved by different fractional
														receptor occupancies. Colloquially, efficacy is “what the drug
														does once it binds to the receptor”.</p>
												</div>
											</div>
											<div class="modal-footer">
												<button type="button" class="btn waves-effect waves-light red"
													data-dismiss="modal">Close</button>
											</div>
										</div>
									</div>
								</div>
								<input type="range" autocomplete="off" name="efficacy" id="effaffslider" min="-0.7"
									max="0" step="0.01" value="-0.35" oninput="updateEfficacyAff(this.value)">
							</fieldset>
							<fieldset style="width: 430px;">
								<legend>Cell</legend>
								<label for="density">Receptor Density (R<sub>T</sub>)&nbsp</label><a data-toggle="modal"
									href="" data-target="#info15"><i class="red1 fa fa-info-circle"></i></a>
								<div id="info15" class="modal fade" role="dialog">
									<div class="modal-dialog">
										<div class="modal-content">
											<div class="modal-header">
												<h4 class="modal-title">Receptor Density</h4>
											</div>
											<div class="modal-body">
												<div class="box">
													<p><b>Receptor Density</b> is the total number of receptors,
														expressed in terms of unit area of membrane, or per cell, or per
														unit mass of protein. Proportional to the quantity
														B<sub>max</sub> (the maximal specific binding of a ligand, often
														expressed in units of mol ligand/mg protein, or ligands
														bound/cell) measured in radioligand binding studies. The
														relationship between B<sub>max</sub> and N is influenced by the
														number of ligand binding sites possessed by each receptor. For
														most receptors there is one binding site for the endogenous
														agonist, although for ligand-gated ion channels (e.g. nicotinic
														acetylcholine receptor), this is generally more than one.</p>
												</div>
											</div>
											<div class="modal-footer">
												<button type="button" class="btn waves-effect waves-light red"
													data-dismiss="modal">Close</button>
											</div>
										</div>
									</div>
								</div>

								<input type="range" autocomplete="off" name="density" id="denaffslider" min="-1" max="1"
									step="0.01" value="0" oninput="updateDensityAff(this.value)">
								<br><label for="efficiency">Signal Amplification (<i>&#947</i>)&nbsp</label><a
									data-toggle="modal" href="" data-target="#info16"><i
										class="red1 fa fa-info-circle"></i></a>

								<div id="info16" class="modal fade" role="dialog">
									<div class="modal-dialog">
										<div class="modal-content">
											<div class="modal-header">
												<h4 class="modal-title">Signal Amplification</h4>
											</div>
											<div class="modal-body">
												<div class="box">

													<p><b>Signal Amplification</b> is a cell-dependent parameter
														describing the efficiency of the signalling pathways that couple
														(link) the activated receptor to the measured effect. Some cells
														have high coupling efficiencies, meaning that activation of a
														relatively small number of receptors can lead to a large
														cellular
														response. Other cells may have low coupling efficiencies
														(perhaps
														due to low expression / activity of a key signalling pathway
														component)
														and high levels of receptor activation may produce relatively
														small cellular responses.</p>

												</div>
											</div>
											<div class="modal-footer">
												<button type="button" class="btn waves-effect waves-light red"
													data-dismiss="modal">Close</button>
											</div>
										</div>
									</div>
								</div>
								<input type="range" autocomplete="off" name="efficiency" id="efficiaffslider" min="0"
									max="2" step="0.01" value="1" oninput="updateEfficiencyAff(this.value)">
							</fieldset>
							<fieldset style="width: 430px;">
								<legend>Allosteric Antagonist</legend>
								<label for="agoaffinity">Affinity (&#8733 1/K<sub>B</sub>)&nbsp</label>
								<input type="range" autocomplete="off" name="agoaffinity" id="agoaffslider" min="7"
									max="11" step="0.04" value="9" oninput="updateAgoAffinityAff(this.value)"><br>
								<label for="antagoaff">-logK<sub>B</sub> =&nbsp</label>
								<input class="numbox" type="number" autocomplete="off" name="antagoaff" id="antagoaff"
									style="width: 60px;" readonly>
								<br><label for="effect">Cooperativity Factor (&#945)&nbsp</label><a data-toggle="modal"
									href="" data-target="#info17"><i class="red1 fa fa-info-circle"></i></a>
								<div id="info17" class="modal fade" role="dialog">
									<div class="modal-dialog">
										<div class="modal-content">
											<div class="modal-header">
												<h4 class="modal-title">Cooperativity Factor</h4>
											</div>
											<div class="modal-body">
												<div class="box">
													<p>The <b>Cooperativity Factor &#945</b> indicates the maximum
														effect produced by the allosteric antagonist on agonist affinity
														– a value of 0.1 indicates that the allosteric antagonist can
														produce up to a 10-fold reduction in agonist affinity. Observe
														the effects of changing the affinity and/or cooperativity factor
														(&#945) of the Allosteric Antagonist on the shape and position
														of the Agonist dose-response curve by moving the red slider
														along the grey bar to the right or left to increase or decrease
														the value of the characteristic, respectively.</p>
												</div>
											</div>
											<div class="modal-footer">
												<button type="button" class="btn waves-effect waves-light red"
													data-dismiss="modal">Close</button>
											</div>
										</div>
									</div>
								</div>
								<input type="range" autocomplete="off" name="effect" id="agoeffaffslider" min="0"
									max="2" step="0.001" value="1" oninput="updateAgoEffectAff(this.value)">
								<br />
								<label for="antcoopaff">&#945 =&nbsp</label>
								<input class="numbox" type="number" autocomplete="off" name="antcoopaff" id="antcoopaff"
									readonly>
							</fieldset>
							<fieldset style="width:450px;text-align:center">
								<legend>Questions</legend>
								<div id="affQuestion" style="margin-bottom:20px"></div>
								<div id="restartMessageAff" style="display:none">There are no more questions. Would you
									like to try again?<br><br></div>

								<div id="affAnswerModal" class="modal fade" role="dialog">
									<div class="modal-dialog">
										<div class="modal-content">
											<div class="modal-header">
												<h4 class="modal-title">Answer</h4>
											</div>
											<div class="modal-body">
												<div class="box">
													<div id="affAnswer"></div>
												</div>
											</div>
											<div class="modal-footer">
												<button type="button" class="btn waves-effect waves-light red"
													data-dismiss="modal">Close</button>
											</div>
										</div>
									</div>
								</div>

								<button id="restartQuestionAff" style="display:none" type="button"
									class="btn waves-effect waves-light red qbutton"
									onclick="restartQuestionAff()">Restart</button>
								<button id="prevAffQuestion" style="float:left" type="button"
									class="btn waves-effect waves-light red qbutton"
									onclick="prevQuestionAff()">Previous Question</button>
								<button id="revealAffAnswer" type="button"
									class="btn waves-effect waves-light red qbutton" onclick="revealAnswerAff()">Reveal
									Answer</button>
								<button id="nextAffQuestion" style="float:right" type="button"
									class="btn waves-effect waves-light red qbutton" onclick="nextQuestionAff()">Next
									Question</button>
							</fieldset>

						</div>
						<div class="col-lg-7">
							<fieldset>
								<legend>Effect of an Allosteric Antagonist on Agonist Dose Response Curve</legend>
								<h5 class="warning" id="affalert"></h5>
								<div id="alloaffin"></div>
							</fieldset>
							<button id="reset" type="button" class="btn waves-effect waves-light red"
								onclick="resetAff()" style="float: right;">Reset</button>

							<!-- NEW - ALLOW CHANGING OF nM Values-->

							<fieldset style="width: 430px;">
								<legend>Antagonist Concentration (M)</legend>
								<label>[Antagonist] #1 : 1.0e</label>
								<input class="numbox" type="number" autocomplete="off" id="affline2" min="-12" max="0"
									style="width: 100px; background-color: yellow;" value="-9" step="0.1"
									oninput="updateConcentrationAff(this.value, 1)"></br>
								<label>[Antagonist] #2 : 1.0e</label>
								<input class="numbox" type="number" autocomplete="off" id="affline3" min="-12" max="0"
									style="width: 100px; background-color: rgb(13, 228, 13);" value="-8" step="0.1"
									oninput="updateConcentrationAff(this.value, 2)"></br>

								<label>[Antagonist] #3 : 1.0e</label>
								<input class="numbox" type="number" autocomplete="off" id="affline4" min="-12" max="0"
									style="width: 100px; background-color: red;" value="-7" step="0.1"
									oninput="updateConcentrationAff(this.value, 3)"></br>
								<label>[Antagonist] #4 : 1.0e</label>
								<input class="numbox" type="number" autocomplete="off" id="affline5" min="-12" max="0"
									style="width: 100px; background-color: #4D8BFF;" value="-6" step="0.1"
									oninput="updateConcentrationAff(this.value, 4)"></br>
							</fieldset>
						</div>
					</div>
				</div>
			</div>
			<!-- Allosteric Antagonist Efficacy -->

			<div id="menu4" class="container tab-pane fade">
				<div class="col col-lg-12">
					<div class="row">
						<div class="col-lg-5" style="padding-top: 50px;">
							<a data-toggle="modal" href="" data-target="#whattodo5"
								class="btn waves-effect waves-light red" role="button"><span
									class="fa fa-info-circle"></span>&nbspAllosteric Antagonist</a>
							<div id="whattodo5" class="modal fade" role="dialog">
								<div class="modal-dialog">
									<div class="modal-content">
										<div class="modal-header">
											<h4 class="modal-title">Allosteric Antagonist (Efficacy)</h4>
										</div>
										<div class="modal-body">
											<div class="box">

												<p>Allosteric antagonists bind reversibly to receptors, without
													activating the receptor, at a site that is different from the
													agonist binding site. Some allosteric antagonists primarily reduce
													agonist efficacy (without changing affinity), thereby inhibiting
													agonist-induced effects.

												<div style='text-align:center'>
													<video width="320" height="240" controls>
														<source src="images/Allosteric Receptor Antagonist efficacy.mp4"
															type="video/mp4">
													</video>
												</div>
												<br>

												They are also referred to as negative allosteric modulators (NAMs).
												Unlike competitive antagonists, the effects of an allosteric antagonist
												are saturable – this is because once the allosteric site is saturated,
												there are no further allosteric effects on the agonist. Allosteric
												antagonism is another form of non-competitive antagonism, as a receptor
												can bind both the agonist and the allosteric antagonist simultaneously.
												</p>
												<img src="images/allostericeffchart.png" alt="Efficacy Chart"
													style="max-height: 100%; max-width: 100%;" />

											</div>
										</div>
										<div class="modal-footer">
											<button type="button" class="btn waves-effect waves-light red"
												data-dismiss="modal">Close</button>
										</div>
									</div>
								</div>
							</div>
							<fieldset style="width: 430px;">
								<legend>Agonist</legend>
								<label for="affinity">Affinity (&#8733 1/K<sub>A</sub>)&nbsp</label><a
									data-toggle="modal" href="" data-target="#info18"><i
										class="red1 fa fa-info-circle"></i></a>
								<div id="info18" class="modal fade" role="dialog">
									<div class="modal-dialog">
										<div class="modal-content">
											<div class="modal-header">
												<h4 class="modal-title">Affinity</h4>
											</div>
											<div class="modal-body">
												<div class="box">
													<p><b>Affinity</b> is a measure of the strength of binding of a drug
														to a receptor
														(both agonists and antagonists have affinity), and depends on
														the existence of chemical
														forces of attraction between the agonist and the receptor
														binding site (e.g. most
														commonly ionic bonds, hydrogen bonds, van der Waals forces). The
														strength of binding
														(affinity) depends upon the respective 3-D structures of the
														agonist and binding site –
														the strength of binding dissipates markedly as the distance
														between the agonist and
														binding site increases. High affinity agonists bind to binding
														sites at low concentrations,
														whereas low affinity agonists bind at higher concentrations. The
														affinity of ligands
														(agonists and antagonists) can be quantitated using the
														Equilibrium Dissociation
														Constant (K<sub>A</sub>), which is the concentration of ligand
														needed to occupy
														(bind to) 50% of receptors (in the absence of any competing
														ligands). K<sub>A</sub>
														is also the ratio of the rate the ligand (agonist or antagonist)
														leaves the receptor
														binding site (k<sub>off</sub>) and the rate it approaches the
														receptor binding site
														(k<sub>on</sub>). The K<sub>A</sub> value is inversely
														proportional to the affinity
														(high affinity ligands have low K<sub>A</sub> values, and vice
														versa) and is
														typically measured in drug binding assays (plots of [ligand]
														versus fractional
														receptor occupancy). As the [ligand] increases the fraction of
														receptor bound
														increases nonlinearly (rectangular hyperbolic function) to form
														a maximal asymptote
														(from which R<sub>T</sub> can be determined). Colloquially
														speaking, “affinity is
														what brings the drug to the receptor”.</p>

													<div style='text-align:center'>
														<video width="320" height="240" controls>
															<source
																src="images\[Ligand] and affinity on receptor binding.mp4"
																type="video/mp4">
														</video>
													</div>
												</div>
											</div>
											<div class="modal-footer">
												<button type="button" class="btn waves-effect waves-light red"
													data-dismiss="modal">Close</button>
											</div>
										</div>
									</div>
								</div>
								<input type="range" autocomplete="off" name="affinity" id="affeffslider" min="5" max="9"
									step="0.04" value="7" oninput="updateAffinityEff(this.value)">
								<br><label for="efficacy">Intrinsic Efficacy (&#949)&nbsp</label><a data-toggle="modal"
									href="" data-target="#info19"><i class="red1 fa fa-info-circle"></i></a>
								<div id="info19" class="modal fade" role="dialog">
									<div class="modal-dialog">
										<div class="modal-content">
											<div class="modal-header">
												<h4 class="modal-title">Intrinsic Efficacy</h4>
											</div>
											<div class="modal-body">
												<div class="box">
													<p><b>Intrinsic Efficacy</b> is the property of the agonist that
														enables it, once bound, to change the conformation of the
														receptor (activation), such that it alters the activity of
														downstream signalling pathways to produce a change in cellular
														activity. Efficacy is measured in relative terms, having no
														absolute scale – but different ligands have clearly different
														efficacies – full agonists have higher efficacies than partial
														agonists, and antagonists typically have no efficacy (bind to
														but don’t activate the receptor). Thus, different agonists have
														different inherent capacities to induce a response, and equal
														cellular responses can be achieved by different fractional
														receptor occupancies. Colloquially, efficacy is “what the drug
														does once it binds to the receptor”.</p>
												</div>
											</div>
											<div class="modal-footer">
												<button type="button" class="btn waves-effect waves-light red"
													data-dismiss="modal">Close</button>
											</div>
										</div>
									</div>
								</div>

								<input type="range" autocomplete="off" name="efficacy" id="effeffslider" min="-0.7"
									max="0" step="0.01" value="-0.35" oninput="updateEfficacyEff(this.value)">
							</fieldset>
							<fieldset style="width: 430px;">
								<legend>Cell</legend>
								<label for="density">Receptor Density (R<sub>T</sub>)&nbsp</label><a data-toggle="modal"
									href="" data-target="#info20"><i class="red1 fa fa-info-circle"></i></a>
								<div id="info20" class="modal fade" role="dialog">
									<div class="modal-dialog">
										<div class="modal-content">
											<div class="modal-header">
												<h4 class="modal-title">Receptor Density</h4>
											</div>
											<div class="modal-body">
												<div class="box">
													<p><b>Receptor Density</b> is the total number of receptors,
														expressed in terms of unit area of membrane, or per cell, or per
														unit mass of protein. Proportional to the quantity
														B<sub>max</sub> (the maximal specific binding of a ligand, often
														expressed in units of mol ligand/mg protein, or ligands
														bound/cell) measured in radioligand binding studies. The
														relationship between B<sub>max</sub> and N is influenced by the
														number of ligand binding sites possessed by each receptor. For
														most receptors there is one binding site for the endogenous
														agonist, although for ligand-gated ion channels (e.g. nicotinic
														acetylcholine receptor), this is generally more than one.</p>
												</div>
											</div>
											<div class="modal-footer">
												<button type="button" class="btn waves-effect waves-light red"
													data-dismiss="modal">Close</button>
											</div>
										</div>
									</div>
								</div>

								<input type="range" autocomplete="off" name="density" id="deneffslider" min="-1" max="1"
									step="0.01" value="0" oninput="updateDensityEff(this.value)">
								<br><label for="efficiency">Signal Amplification (<i>&#947</i>)&nbsp</label><a
									data-toggle="modal" href="" data-target="#info21"><i
										class="red1 fa fa-info-circle"></i></a>

								<div id="info21" class="modal fade" role="dialog">
									<div class="modal-dialog">
										<div class="modal-content">
											<div class="modal-header">
												<h4 class="modal-title">Signal Amplification</h4>
											</div>
											<div class="modal-body">
												<div class="box">

													<p><b>Signal Amplification</b> is a cell-dependent parameter
														describing the efficiency of the signalling pathways that couple
														(link) the activated receptor to the measured effect. Some
														cells have high coupling efficiencies, meaning that activation
														of a relatively small number of receptors can lead to a large
														cellular response. Other cells may have low coupling
														efficiencies
														(perhaps due to low expression / activity of a key signalling
														pathway component) and high levels of receptor activation may
														produce relatively small cellular responses.</p>

												</div>
											</div>
											<div class="modal-footer">
												<button type="button" class="btn waves-effect waves-light red"
													data-dismiss="modal">Close</button>
											</div>
										</div>
									</div>
								</div>
								<input type="range" autocomplete="off" name="efficiency" id="efficieffslider" min="0"
									max="2" step="0.01" value="1" oninput="updateEfficiencyEff(this.value)">
							</fieldset>
							<fieldset style="width: 430px;">
								<legend>Allosteric Antagonist</legend>
								<label for="agoaffinity">Affinity (&#8733 1/K<sub>B</sub>)&nbsp</label>
								<input type="range" autocomplete="off" name="agoaffinity" id="agoaffeffslider" min="7"
									max="11" step="0.04" value="9" oninput="updateAgoAffinityEff(this.value)"><br />
								<label for="antagoeff">-logK<sub>B</sub> =&nbsp</label>
								<input class="numbox" type="number" autocomplete="off" name="antagoeff" id="antagoeff"
									style="width: 60px;" readonly>
								<br><label for="effect">Cooperativity Factor (&#946)&nbsp</label><a data-toggle="modal"
									href="" data-target="#info22"><i class="red1 fa fa-info-circle"></i></a>
								<div id="info22" class="modal fade" role="dialog">
									<div class="modal-dialog">
										<div class="modal-content">
											<div class="modal-header">
												<h4 class="modal-title">Cooperativity Factor</h4>
											</div>
											<div class="modal-body">
												<div class="box">
													<p>The <b>Cooperativity Factor &#946</b> indicates the maximum
														effect produced by the allosteric antagonist on agonist
														efficacy. Observe the effects of changing the affinity and/or
														cooperativity factor (&#946) of the Allosteric Antagonist on the
														shape and position of the Agonist dose-response curve by moving
														the red slider along the grey bar to the right or left to
														increase or decrease the value of the characteristic,
														respectively.</p>
												</div>
											</div>
											<div class="modal-footer">
												<button type="button" class="btn waves-effect waves-light red"
													data-dismiss="modal">Close</button>
											</div>
										</div>
									</div>
								</div>
								<input type="range" autocomplete="off" name="effect" id="agoeffeffslider" min="0"
									max="2" step="0.001" value="1" oninput="updateAgoEffectEff(this.value)"><br />
								<label for="antcoopeff">&#946 =&nbsp</label>
								<input class="numbox" type="number" autocomplete="off" name="antcoopeff" id="antcoopeff"
									style="width: 65px;" readonly>
							</fieldset>
							<fieldset style="width:450px;text-align:center">
								<legend>Questions</legend>
								<div id="effQuestion" style="margin-bottom:20px"></div>
								<div id="restartMessageEff" style="display:none">There are no more questions. Would you
									like to try again?<br><br></div>


								<div id="effAnswerModal" class="modal fade" role="dialog">
									<div class="modal-dialog">
										<div class="modal-content">
											<div class="modal-header">
												<h4 class="modal-title">Answer</h4>
											</div>
											<div class="modal-body">
												<div class="box">
													<div id="effAnswer"></div>
												</div>
											</div>
											<div class="modal-footer">
												<button type="button" class="btn waves-effect waves-light red"
													data-dismiss="modal">Close</button>
											</div>
										</div>
									</div>
								</div>

								<button id="restartQuestionEff" style="display:none" type="button"
									class="btn waves-effect waves-light red qbutton"
									onclick="restartQuestionEff()">Restart</button>
								<button id="prevEffQuestion" style="float:left" type="button"
									class="btn waves-effect waves-light red qbutton"
									onclick="prevQuestionEff()">Previous Question</button>
								<button id="revealEffAnswer" type="button"
									class="btn waves-effect waves-light red qbutton" onclick="revealAnswerEff()">Reveal
									Answer</button>
								<button id="nextEffQuestion" style="float:right" type="button"
									class="btn waves-effect waves-light red qbutton" onclick="nextQuestionEff()">Next
									Question</button>
							</fieldset>
						</div>
						<div class="col-lg-7">
							<fieldset>
								<legend>Effect of an Allosteric Antagonist on Agonist Dose Response Curve</legend>
								<h5 class="warning" id="effalert"></h5>
								<div id="alloeffic"></div>
							</fieldset>
							<button id="reset" type="button" class="btn waves-effect waves-light red"
								onclick="resetEff()" style="float: right;">Reset</button>

							<!-- NEW - ALLOW CHANGING OF nM Values-->

							<fieldset style="width: 430px;">
								<legend>Antagonist Concentration (M)</legend>
								<label>[Antagonist] #1 : 1.0e</label>
								<input class="numbox" type="number" autocomplete="off" id="effline2" min="-12" max="0"
									style="width: 100px; background-color: yellow;" value="-9" step="0.1"
									oninput="updateConcentrationEff(this.value, 1)"></br>

								<label>[Antagonist] #2 : 1.0e</label>
								<input class="numbox" type="number" autocomplete="off" id="effline3" min="-12" max="0"
									style="width: 100px; background-color: rgb(13, 228, 13);" value="-8" step="0.1"
									oninput="updateConcentrationEff(this.value, 2)"></br>

								<label>[Antagonist] #3 : 1.0e</label>
								<input class="numbox" type="number" autocomplete="off" id="effline4" min="-12" max="0"
									style="width: 100px; background-color: red;" value="-7" step="0.1"
									oninput="updateConcentrationEff(this.value, 3)"></br>

								<label>[Antagonist] #4 : 1.0e</label>
								<input class="numbox" type="number" autocomplete="off" id="effline5" min="-12" max="0"
									style="width: 100px; background-color: #4D8BFF;" value="-6" step="0.1"
									oninput="updateConcentrationEff(this.value, 4)"></br>
							</fieldset>

						</div>
					</div>
				</div>
			</div>
			<!-- This section corresponds to the Functional Antagonist -->

			<div id="menu5" class="container tab-pane fade">
				<div class="col col-lg-12">
					<div class="row">
						<div class="col-lg-5" style="padding-top: 5px;">
							<a data-toggle="modal" href="" data-target="#whattodo6"
								class="btn waves-effect waves-light red" role="button"><span
									class="fa fa-info-circle"></span>&nbspFunctional Antagonist</a>
							<div id="whattodo6" class="modal fade" role="dialog">
								<div class="modal-dialog">
									<div class="modal-content">
										<div class="modal-header">
											<h4 class="modal-title">Functional Antagonist</h4>
										</div>
										<div class="modal-body">
											<div class="box">

												<p>Functional antagonists are agonists that produce a functional effect
													in the cell that is the opposite of that produced by another agonist
													(e.g. agonist A constricts smooth muscle, whereas agonist B relaxes
													smooth muscle).

												<div style='text-align:center'>
													<video width="320" height="240" controls>
														<source src="images/Functional Antagonist.mp4" type="video/mp4">
													</video>
												</div>
												<br>

												The net effect produced depends upon the relative properties of the
												respective agonists (affinity & efficacy) and their signalling pathways
												(R<sub>T</sub> & Signal Amplification).
												</p>
												<img src="images/functionalchart.png" alt="Functional Chart"
													style="max-height: 100%; max-width: 100%;" /><br />
												<br>
												<p>An example of a functional antagonist would be salbutamol, which by
													activating &#946<sub>2</sub>-adrenoceptors on airway smooth muscle
													and producing relaxation can functionally antagonise airway smooth
													muscle contraction induced by a wide array of spasmogenic agonists
													including acetylcholine, histamine and leukotrienes, each acting
													through their own specific receptors.</p>

											</div>
										</div>
										<div class="modal-footer">
											<button type="button" class="btn waves-effect waves-light red"
												data-dismiss="modal">Close</button>
										</div>
									</div>
								</div>
							</div>
							<fieldset style="width: 430px;">
								<legend>Agonist</legend>
								<label for="affinity">Affinity (&#8733 1/K<sub>A</sub>)&nbsp</label><a
									data-toggle="modal" href="" data-target="#info23"><i
										class="red1 fa fa-info-circle"></i></a>
								<div id="info23" class="modal fade" role="dialog">
									<div class="modal-dialog">
										<div class="modal-content">
											<div class="modal-header">
												<h4 class="modal-title">Affinity</h4>
											</div>
											<div class="modal-body">
												<div class="box">
													<p><b>Affinity</b> is a measure of the strength of binding of a drug
														to a receptor
														(both agonists and antagonists have affinity), and depends on
														the existence of chemical
														forces of attraction between the agonist and the receptor
														binding site (e.g. most
														commonly ionic bonds, hydrogen bonds, van der Waals forces). The
														strength of binding
														(affinity) depends upon the respective 3-D structures of the
														agonist and binding site –
														the strength of binding dissipates markedly as the distance
														between the agonist and
														binding site increases. High affinity agonists bind to binding
														sites at low concentrations,
														whereas low affinity agonists bind at higher concentrations. The
														affinity of ligands
														(agonists and antagonists) can be quantitated using the
														Equilibrium Dissociation
														Constant (K<sub>A</sub>), which is the concentration of ligand
														needed to occupy
														(bind to) 50% of receptors (in the absence of any competing
														ligands). K<sub>A</sub>
														is also the ratio of the rate the ligand (agonist or antagonist)
														leaves the receptor
														binding site (k<sub>off</sub>) and the rate it approaches the
														receptor binding site
														(k<sub>on</sub>). The K<sub>A</sub> value is inversely
														proportional to the affinity
														(high affinity ligands have low K<sub>A</sub> values, and vice
														versa) and is
														typically measured in drug binding assays (plots of [ligand]
														versus fractional
														receptor occupancy). As the [ligand] increases the fraction of
														receptor bound
														increases nonlinearly (rectangular hyperbolic function) to form
														a maximal asymptote
														(from which R<sub>T</sub> can be determined). Colloquially
														speaking, “affinity is
														what brings the drug to the receptor”.</p>

													<div style='text-align:center'>
														<video width="320" height="240" controls>
															<source
																src="images\[Ligand] and affinity on receptor binding.mp4"
																type="video/mp4">
														</video>
													</div>
												</div>
											</div>
											<div class="modal-footer">
												<button type="button" class="btn waves-effect waves-light red"
													data-dismiss="modal">Close</button>
											</div>
										</div>
									</div>
								</div>
								<input type="range" autocomplete="off" name="affinity" id="afffunslider" min="5" max="9"
									step="0.04" value="7" oninput="updateAffinityFun(this.value)">
								<br><label for="efficacy">Intrinsic Efficacy (&#949)&nbsp</label><a data-toggle="modal"
									href="" data-target="#info24"><i class="red1 fa fa-info-circle"></i></a>
								<div id="info24" class="modal fade" role="dialog">
									<div class="modal-dialog">
										<div class="modal-content">
											<div class="modal-header">
												<h4 class="modal-title">Intrinsic Efficacy</h4>
											</div>
											<div class="modal-body">
												<div class="box">
													<p><b>Intrinsic Efficacy</b> is the property of the agonist that
														enables it, once bound, to change the conformation of the
														receptor (activation), such that it alters the activity of
														downstream signalling pathways to produce a change in cellular
														activity. Efficacy is measured in relative terms, having no
														absolute scale – but different ligands have clearly different
														efficacies – full agonists have higher efficacies than partial
														agonists, and antagonists typically have no efficacy (bind to
														but don’t activate the receptor). Thus, different agonists have
														different inherent capacities to induce a response, and equal
														cellular responses can be achieved by different fractional
														receptor occupancies. Colloquially, efficacy is “what the drug
														does once it binds to the receptor”.</p>
												</div>
											</div>
											<div class="modal-footer">
												<button type="button" class="btn waves-effect waves-light red"
													data-dismiss="modal">Close</button>
											</div>
										</div>
									</div>
								</div>
								<input type="range" autocomplete="off" name="efficacy" id="efffunslider" min="-0.7"
									max="0" step="0.01" value="-0.35" oninput="updateEfficacyFun(this.value)">
								<fieldset>
									<legend>Cell</legend>
									<label for="density">Receptor Density (R<sub>T</sub>)&nbsp</label><a
										data-toggle="modal" href="" data-target="#info25"><i
											class="red1 fa fa-info-circle"></i></a>
									<div id="info25" class="modal fade" role="dialog">
										<div class="modal-dialog">
											<div class="modal-content">
												<div class="modal-header">
													<h4 class="modal-title">Receptor Density</h4>
												</div>
												<div class="modal-body">
													<div class="box">
														<p><b>Receptor Density</b> is the total number of receptors,
															expressed in terms of unit area of membrane, or per cell, or
															per unit mass of protein. Proportional to the quantity
															B<sub>max</sub> (the maximal specific binding of a ligand,
															often expressed in units of mol ligand/mg protein, or
															ligands bound/cell) measured in radioligand binding studies.
															The relationship between B<sub>max</sub> and N is influenced
															by the number of ligand binding sites possessed by each
															receptor. For most receptors there is one binding site for
															the endogenous agonist, although for ligand-gated ion
															channels (e.g. nicotinic acetylcholine receptor), this is
															generally more than one.</p>
													</div>
												</div>
												<div class="modal-footer">
													<button type="button" class="btn waves-effect waves-light red"
														data-dismiss="modal">Close</button>
												</div>
											</div>
										</div>
									</div>

									<input type="range" autocomplete="off" name="density" id="denfunslider" min="-1"
										max="1" step="0.01" value="0" oninput="updateDensityFun(this.value)">
									<br><label for="efficiency">Signal Amplification (<i>&#947</i>)&nbsp</label><a
										data-toggle="modal" href="" data-target="#info26"><i
											class="red1 fa fa-info-circle"></i></a>
									<div id="info26" class="modal fade" role="dialog">
										<div class="modal-dialog">
											<div class="modal-content">
												<div class="modal-header">
													<h4 class="modal-title">Coupling Efficiency</h4>
												</div>
												<div class="modal-body">
													<div class="box">
														<p><b>Signal Amplification</b> is a cell-dependent parameter
															describing the
															efficiency of the signalling pathways that couple (link) the
															activated
															receptor to the measured effect. Some cells have high
															coupling efficiencies,
															meaning that activation of a relatively small number of
															receptors can lead to
															a large cellular response. Other cells may have low coupling
															efficiencies
															(perhaps due to low expression / activity of a key
															signalling pathway component)
															and high levels of receptor activation may produce
															relatively small cellular responses.</p>
													</div>
												</div>
												<div class="modal-footer">
													<button type="button" class="btn waves-effect waves-light red"
														data-dismiss="modal">Close</button>
												</div>
											</div>
										</div>
									</div>
									<input type="range" autocomplete="off" name="efficiency" id="efficifunslider"
										min="0" max="2" step="0.01" value="1" oninput="updateEfficiencyFun(this.value)">
								</fieldset>
							</fieldset>
							<fieldset style="width: 430px;">
								<legend>Functional Antagonist</legend>
								<label for="agoaffinity">Affinity (&#8733 1/K<sub>B</sub>)&nbsp</label>
								<input type="range" autocomplete="off" name="agoaffinity" id="agoafffunslider" min="5"
									max="9" step="0.04" value="7" oninput="updateAgoAffinityFun(this.value)">
								<br><label for="effect">Intrinsic Efficacy (&#949)&nbsp</label>
								<input type="range" autocomplete="off" name="effect" id="agoefffunslider" min="-0.7"
									max="0" step="0.01" value="-0.35" oninput="updateAgoEfficacyFun(this.value)">
								<!--value was -0.216-->
								<fieldset>
									<legend>Cell</legend>
									<label for="density">Receptor Density (R<sub>T</sub>)&nbsp</label>
									<input type="range" autocomplete="off" name="density" id="agodenfunslider" min="-1"
										max="1" step="0.01" value="0" oninput="updateAgoDensityFun(this.value)">
									<!--value was -0.216-->

									<br><label for="efficiency">Signal Amplification (<i>&#947</i>)&nbsp</label>
									<input type="range" autocomplete="off" name="efficiency" id="agoefficifunslider"
										min="0" max="2" step="0.01" value="1"
										oninput="updateAgoEfficiencyFun(this.value)">

									<!--value was -0.216-->
								</fieldset>
							</fieldset>
							<fieldset style="width:450px;text-align:center">
								<legend>Questions</legend>
								<div id="funQuestion" style="margin-bottom:20px;"></div>
								<div id="restartMessageFun" style="display:none">There are no more questions. Would you
									like to try again?<br><br></div>


								<div id="funAnswerModal" class="modal fade" role="dialog">
									<div class="modal-dialog">
										<div class="modal-content">
											<div class="modal-header">
												<h4 class="modal-title">Answer</h4>
											</div>
											<div class="modal-body">
												<div class="box">
													<div id="funAnswer"></div>
												</div>
											</div>
											<div class="modal-footer">
												<button type="button" class="btn waves-effect waves-light red"
													data-dismiss="modal">Close</button>
											</div>
										</div>
									</div>
								</div>

								<button id="restartQuestionFun" style="display:none" type="button"
									class="btn waves-effect waves-light red qbutton"
									onclick="restartQuestionFun()">Restart</button>
								<button id="prevFunQuestion" style="float:left" type="button"
									class="btn waves-effect waves-light red qbutton"
									onclick="prevQuestionFun()">Previous Question</button>
								<button id="revealFunAnswer" type="button"
									class="btn waves-effect waves-light red qbutton" onclick="revealAnswerFun()">Reveal
									Answer</button>
								<button id="nextFunQuestion" style="float:right" type="button"
									class="btn waves-effect waves-light red qbutton" onclick="nextQuestionFun()">Next
									Question</button>
							</fieldset>
						</div>
						<div class="col-lg-7" style="padding-top: 40px;">
							<fieldset>
								<legend>Effect of a Functional Antagonist on Agonist Dose Response Curve</legend>
								<h5 class="warning" id="funalert"></h5>
								<div id="functional"></div>
							</fieldset>
							<button id="reset" type="button" class="btn waves-effect waves-light red"
								onclick="resetFun()" style="float: right;">Reset</button>

							<!-- NEW - ALLOW CHANGING OF nM Values-->

							<fieldset style="width: 430px;">
								<legend>Antagonist Concentration (M)</legend>
								<label>[Antagonist] #1 : 1.0e</label>
								<input class="numbox" type="number" autocomplete="off" id="funline2" min="-12" max="0"
									style="width: 100px; background-color: yellow;" value="-9" step="0.1"
									oninput="updateConcentrationFun(this.value, 1)"></br>

								<label>[Antagonist] #2 : 1.0e</label>
								<input class="numbox" type="number" autocomplete="off" id="funline3" min="-12" max="0"
									style="width: 100px; background-color: rgb(13, 228, 13);" value="-8" step="0.1"
									oninput="updateConcentrationFun(this.value, 2)"></br>

								<label>[Antagonist] #3 : 1.0e</label>
								<input class="numbox" type="number" autocomplete="off" id="funline4" min="-12" max="0"
									style="width: 100px; background-color: red;" value="-7" step="0.1"
									oninput="updateConcentrationFun(this.value, 3)"></br>

								<label>[Antagonist] #4 : 1.0e</label>
								<input class="numbox" type="number" autocomplete="off" id="funline5" min="-12" max="0"
									style="width: 100px; background-color: #4D8BFF;" value="-6" step="0.1"
									oninput="updateConcentrationFun(this.value, 4)"></br>
							</fieldset>
						</div>
					</div>
				</div>
			</div>

			<!-- This section corresponds to the Inverse Agonist -->
			<div id="menu6" class="container tab-pane fade">
				<div class="col col-lg-12">
					<div class="row">
						<div class="col-lg-5" style="padding-top:50px">
							<a data-toggle="modal" href="" data-target="#whattodo7"
								class="btn waves-effect waves-light red" role="button"><span
									class="fa fa-info-circle"></span>&nbspInverse Agonist</a>
							<div id="whattodo7" class="modal fade" role="dialog">
								<div class="modal-dialog">
									<div class="modal-content">
										<!-- The Inverse Agonist button -->
										<div class="modal-header">
											<h4 class="modal-title">Inverse Agonist</h4>
										</div>
										<div class="modal-body">
											<!-- The contents once Inverse Agonist button is clicked -->
											<div class="box">
												<p> In the late 1980s, Costa and Herz discovered that G protein-coupled
													receptors (GPRCs) can be spontaneously active in the absence of an
													agonist (R<sub>a</sub>*, see top part of the figure below), and
													produce an elevated basal cellular response. This phenomenon is
													termed ‘constitutive receptor activity’, and is associated with two
													important developments.<br><br>
													The first development was the introduction of the ‘extended ternary
													complex model’ (shown below), which recognises that receptors exists
													in equilibrium between (at least) two states, an inactive
													conformation (R<sub>i</sub>, that cannot signal)) and an active
													conformation (R<sub>a</sub>*, that can signal). The ratio of active
													to inactive receptors (R<sub>a</sub>*/R<sub>i</sub>) is termed L and
													describes the isomerisation efficiency of a receptor. L depends upon
													the number and strength of intramolecular stabilising contacts
													within the receptor. A high L value reflects a low energy barrier to
													spontaneous formation of the R<sub>a</sub>* conformation and
													reflects a receptor that is more likely exist in the R<sub>a</sub>*
													conformation, and thereby exhibit constitutive receptor activity.
													The L value is constant for, but will vary considerably between,
													receptor subtypes.<br><br>
													The second key development was the recognition that particular
													ligands, called ‘inverse agonists’, could bind to receptors and
													reduce constitutive receptor activity. A feature of inverse agonists
													is their higher affinity the inactive receptor conformation
													(R<sub>i</sub>) over the active receptor conformation
													(R<sub>a</sub>*). By selectively binding to the inactive receptor
													conformation, inverse agonists increase the proportion of receptors
													in the inactive conformation (R<sub>i</sub>), and decrease the
													population of receptors in the active conformation (R<sub>i</sub>*).
													Inverse agonists are said to have negative intrinsic efficacy.
													Partial inverse agonists are ligands that have greater affinity for
													R<sub>i</sub> than R<sub>a</sub>*, but less selectivity for Ri over
													R<sub>a</sub>*, compared to full inverse agonists.
												<div style='text-align:center'>
													<video width="320" height="240" controls>
														<source src="images\Const. Active Rec. & Inverse agonism.mp4"
															type="video/mp4">
													</video>
												</div> <br>
												In the schema shown below, the term &#945 refers to the fold higher
												affinity the ligand has for the active receptor over the inactive
												receptor, and for an inverse agonist, &#945 < 1. Thus an &#945 value of
													0.1 indicates the inverse agonist has a 10-fold higher affinity for
													the inactive receptor (R<sub>i</sub>) over the active receptor
													(R<sub>a</sub>*). Similarly, the term &#947 refers to the fold
													higher affinity of the receptor for the G protein when the receptor
													is bound by the ligand, and for an inverse agonist, &#947 < 1. Thus
														a &#947 value of 0.1 indicates that the receptor is 10-fold less
														likely to bind to a G protein when it is bound by the inverse
														agonist.<br><br>
														Note, in this model, a conventional agonist that binds to
														activates the receptor will have a higher affinity for Ra* over
														Ri (&#945 > 1) and will promote the binding of the receptor to
														the G protein (&#947 > 1). Furthermore, because the inverse
														agonist binds to the orthosteric site on the receptor, without
														activating the receptor, it will act as a competitive antagonist
														in the absence of constitutive receptor activity.<br><br>
														</p>
														<img src="images/inverseagonistchart.png"
															alt="Inversse Agonist Chart"
															style="max-height: 100%; max-width: 100%;" /><br />
											</div>
										</div>
										<div class="modal-footer">
											<button type="button" class="btn waves-effect waves-light red"
												data-dismiss="modal">Close</button>
										</div>
									</div>
								</div>
							</div>
							<fieldset style="width: 430px;">
								<!-- This is all the content inside the Inverse Agonist box -->

								<legend>Inverse Agonist</legend>
								<label for="affinityinv">Affinity (&#8733 1/K<sub>A</sub>)&nbsp</label>
								<a data-toggle="modal" href="" data-target="#info27"><i
										class="red1 fa fa-info-circle"></i></a>
								<div id="info27" class="modal fade" role="dialog">
									<div class="modal-dialog">
										<div class="modal-content">
											<div class="modal-header">
												<h4 class="modal-title">Affinity</h4>
											</div>
											<div class="modal-body">
												<div class="box">
													<p><b>Affinity</b> is a measure of the strength of binding of a drug
														to a receptor
														(both agonists and antagonists have affinity), and depends on
														the existence of chemical
														forces of attraction between the agonist and the receptor
														binding site (e.g. most
														commonly ionic bonds, hydrogen bonds, van der Waals forces). The
														strength of binding
														(affinity) depends upon the respective 3-D structures of the
														agonist and binding site –
														the strength of binding dissipates markedly as the distance
														between the agonist and
														binding site increases. High affinity agonists bind to binding
														sites at low concentrations,
														whereas low affinity agonists bind at higher concentrations. The
														affinity of ligands
														(agonists and antagonists) can be quantitated using the
														Equilibrium Dissociation
														Constant (K<sub>A</sub>), which is the concentration of ligand
														needed to occupy
														(bind to) 50% of receptors (in the absence of any competing
														ligands). K<sub>A</sub>
														is also the ratio of the rate the ligand (agonist or antagonist)
														leaves the receptor
														binding site (k<sub>off</sub>) and the rate it approaches the
														receptor binding site
														(k<sub>on</sub>). The K<sub>A</sub> value is inversely
														proportional to the affinity
														(high affinity ligands have low K<sub>A</sub> values, and vice
														versa) and is
														typically measured in drug binding assays (plots of [ligand]
														versus fractional
														receptor occupancy). As the [ligand] increases the fraction of
														receptor bound
														increases nonlinearly (rectangular hyperbolic function) to form
														a maximal asymptote
														(from which R<sub>T</sub> can be determined). Colloquially
														speaking, “affinity is
														what brings the drug to the receptor”.</p>

													<div style='text-align:center'>
														<video width="320" height="240" controls>
															<source
																src="images\[Ligand] and affinity on receptor binding.mp4"
																type="video/mp4">
														</video>
													</div>
												</div>
											</div>
											<div class="modal-footer">
												<button type="button" class="btn waves-effect waves-light red"
													data-dismiss="modal">Close</button>
											</div>
										</div>
									</div>
								</div>
								<input type="range" autocomplete="off" name="affinityinv" id="affsliderinv" min="6"
									max="10" step="0.01" value="8" oninput="updateAffinityInv(this.value)">

								<br><label for="selectivity">Selectivity for R<sub>i</sub> (&#945)</label>
								<a data-toggle="modal" href="" data-target="#info28"><i
										class="red1 fa fa-info-circle"></i></a>
								<div id="info28" class="modal fade" role="dialog">
									<div class="modal-dialog">
										<div class="modal-content">
											<div class="modal-header">
												<h4 class="modal-title">Selectivity for R<sub>i</sub> (&#945)</h4>
											</div>
											<div class="modal-body">
												<div class="box">
													<p>
														The term α refers to the fold higher affinity the ligand has for
														the active receptor over the inactive receptor, and for an
														inverse agonist, α < 1. Thus an α value of 0.1 indicates the
															inverse agonist has a 10-fold higher affinity for the
															inactive receptor (R<sub>i</sub>) over the active receptor
															(R<sub>a</sub>*)
													</p>
												</div>
											</div>
											<div class="modal-footer">
												<button type="button" class="btn waves-effect waves-light red"
													data-dismiss="modal">Close</button>
											</div>
										</div>
									</div>
								</div>
								<input type="range" autocomplete="off" name="selectivity" id="selsliderinv" min="-3"
									max="0" step="0.01" value="-1.52" oninput="updateSelectivityInv(this.value)">

								<br><label for="negefficacy">Negative efficacy (&#947)</label>
								<a data-toggle="modal" href="" data-target="#info29"><i
										class="red1 fa fa-info-circle"></i></a>
								<div id="info29" class="modal fade" role="dialog">
									<div class="modal-dialog">
										<div class="modal-content">
											<div class="modal-header">
												<h4 class="modal-title">Negative efficacy (&#947)</h4>
											</div>
											<div class="modal-body">
												<div class="box">
													<p>
														The term γ refers to the fold higher affinity of the receptor
														for the G protein when the receptor is bound by the ligand, and
														for an inverse agonist, γ < 1. Thus a γ value of 0.1 indicates
															that the receptor is 10-fold less likely to bind to a G
															protein when it is bound by the inverse agonist. </p>
												</div>
											</div>
											<div class="modal-footer">
												<button type="button" class="btn waves-effect waves-light red"
													data-dismiss="modal">Close</button>
											</div>
										</div>
									</div>
								</div>
								<input type="range" autocomplete="off" name="negefficacy" id="negeffsliderinv" min="-3"
									max="0" step="0.01" value="-1.52" oninput="updateNegeffInv(this.value)">
							</fieldset>
							<!-- The contents inside the Receptor box -->

							<fieldset style="width: 430px;">
								<legend>Receptor</legend>
								<label for="allconstant">Allosteric constant (L)
									([R<sub>a</sub>]/[R<sub>j</sub>])</label>
								<a data-toggle="modal" href="" data-target="#info30"><i
										class="red1 fa fa-info-circle"></i></a>
								<div id="info30" class="modal fade" role="dialog">
									<div class="modal-dialog">
										<div class="modal-content">
											<div class="modal-header">
												<h4 class="modal-title">Allosteric constant (L)
													([R<sub>a</sub>]/[R<sub>j</sub>])</h4>
											</div>
											<div class="modal-body">
												<div class="box">
													<p>
														The ratio of active to inactive receptors
														(R<sub>a</sub>*/R<sub>i</sub>) is termed L and describes the
														isomerisation efficiency of a receptor. L depends upon the
														number and strength of intramolecular stabilising contacts
														within the receptor. A high L value reflects a low energy
														barrier to spontaneous formation of the R<sub>a</sub>*
														conformation and reflects a receptor that is more likely exist
														in the R<sub>a</sub>* conformation, and thereby exhibit
														constitutive receptor activity. The L value is constant for, but
														will vary considerably between, receptor subtypes.
													</p>
												</div>
											</div>
											<div class="modal-footer">
												<button type="button" class="btn waves-effect waves-light red"
													data-dismiss="modal">Close</button>
											</div>
										</div>
									</div>
								</div>
								<input type="range" autocomplete="off" name="allconstant" id="allsliderinv" min="-2"
									max="1" step="0.01" value="-0.52" oninput="updateAllInv(this.value)">
							</fieldset>
							<!-- The contents inside the quiz box -->
							<fieldset style="width:450px;text-align:center">
								<legend>Questions</legend>
								<div id="invQuestion" style="margin-bottom:20px;"></div>
								<div id="restartMessageInv" style="display:none">There are no more questions. Would you
									like to try again?<br><br></div>


								<div id="invAnswerModal" class="modal fade" role="dialog">
									<div class="modal-dialog">
										<div class="modal-content">
											<div class="modal-header">
												<h4 class="modal-title">Answer</h4>
											</div>
											<div class="modal-body">
												<div class="box">
													<div id="invAnswer"></div>
												</div>
											</div>
											<div class="modal-footer">
												<button type="button" class="btn waves-effect waves-light red"
													data-dismiss="modal">Close</button>
											</div>
										</div>
									</div>
								</div>

								<button id="restartQuestionInv" style="display:none" type="button"
									class="btn waves-effect waves-light red qbutton"
									onclick="restartQuestionInv()">Restart</button>
								<button id="prevInvQuestion" style="float:left" type="button"
									class="btn waves-effect waves-light red qbutton"
									onclick="prevQuestionInv()">Previous Question</button>
								<button id="revealInvAnswer" type="button"
									class="btn waves-effect waves-light red qbutton" onclick="revealAnswerInv()">Reveal
									Answer</button>
								<button id="nextInvQuestion" style="float:right" type="button"
									class="btn waves-effect waves-light red qbutton" onclick="nextQuestionInv()">Next
									Question</button>
							</fieldset>

						</div>
						<!-- The Agonist box -->
						<div class="col-lg-7" style="padding-top: 40px;">
							<fieldset>
								<!--style="display:block"-->
								<legend>Inverse Agonist Dose Response Curve

									<a data-toggle="modal" href="" data-target="#info31"><i
											class="red1 fa fa-info-circle"></i></a>
									<div id="info31" class="modal fade" role="dialog">
										<div class="modal-dialog">
											<div class="modal-content">
												<div class="modal-header">
													<h4 class="modal-title">Inverse Agonist Dose Response Curve</h4>
												</div>
												<div class="modal-body">
													<div class="box">
														<p>
															Shown are a series of 6 dose-response curves to an Inverse
															Agonist. Each curve represents the effect produced by
															increasing concentrations of an Inverse Agonist at
															Constitutively Active Receptors in cells that have
															different, prescribed levels of Signal Amplification
															(0.3-1000). For example, the green curve illustrates the
															effects produced by increasing concentrations of an Inverse
															Agonist in a cell type that has a high level of signal
															amplification (SA=1000), which enables low concentrations of
															constitutively active receptors to produce large cellular
															effects. In this instance, the large cellular effect
															produced by the constitutively active receptors can be
															partially inhibited by high concentrations of the Inverse
															Agonist. In contrast, the light blue curve illustrates the
															effects produced by increasing concentrations of an Inverse
															Agonist in a cell type where there is low signal
															amplification (SA=0.3) and even high concentrations of
															constitutively active receptors produce only small effects.
															In this instance, the small cellular effect produced by the
															constitutively active receptors can be completely inhibited
															by low concentrations of the Inverse Agonist. The shapes and
															positions of the Inverse Agonist dose-response curves will
															change depending upon the characteristics of the Inverse
															Agonist (Affinity, Selectivity, Negative efficacy) and the
															Receptor (Allosteric constant) – these effects can be seen
															using the Dose-Response Visualiser.
														</p>
													</div>
												</div>
												<div class="modal-footer">
													<button type="button" class="btn waves-effect waves-light red"
														data-dismiss="modal">Close</button>
												</div>
											</div>
										</div>
									</div>
								</legend>

								<h5 class="warning" id="invalert"></h5>
								<div id="inverse"></div>
							</fieldset>
							<button id="resetinv" type="button" class="btn waves-effect waves-light red"
								onclick="resetInv()" style="float: right;">Reset</button>
						</div>
					</div>
				</div>
			</div>
		</div>
	</div>


	</div>
	</div>
	<script type="text/javascript" src="js/script.js"></script>
	<script type="text/javascript" src="js/scriptcom.js"></script>
	<script type="text/javascript" src="js/scriptirr.js"></script>
	<script type="text/javascript" src="js/scriptaff.js"></script>
	<script type="text/javascript" src="js/scripteff.js"></script>
	<script type="text/javascript" src="js/scriptfun.js"></script>
	<script type="text/javascript" src="js/scriptinv.js"></script>
	<script src="bootstrap/js/jquery-3.3.1.min.js"></script>
	<script src="bootstrap/js/bootstrap.bundle.min.js"></script>
	<script src='https://cdnjs.cloudflare.com/ajax/libs/d3/3.4.13/d3.min.js'></script>
	<script src='https://cdnjs.cloudflare.com/ajax/libs/trianglify/0.1.5/trianglify.min.js'></script>
	<script type="text/javascript" src="js/triangle.js"></script>


	<footer id="footer" class="footer">
		<div class="container">
			<ul class="list-inline">
				<li class="list-inline-item">
					<a data-toggle="modal" href="" data-target="#about">About</a>
				</li>
				<li class="footer-menu-divider list-inline-item">⋅</li>
				<li class="list-inline-item">
					<a data-toggle="modal" href="" data-target="#instructions">Instructions</a>
				</li>
				<li class="footer-menu-divider list-inline-item">⋅</li>
				<li class="list-inline-item">
					<a data-toggle="modal" href="" data-target="#contact">Contact</a>
				</li>
				<li class="footer-menu-divider list-inline-item">⋅</li>
				<li>
					<a data-toggle="modal" href="" data-target="#references">References</a>
				</li>
			</ul>
			<p class="cc text-muted small">Creative Commons &copy; 2021 </p>
		</div>
		<div id="about" class="modal fade" role="dialog">
			<div class="modal-dialog">
				<div class="modal-content">
					<div class="modal-header">
						<h4 class="modal-title">About</h4>
					</div>
					<div class="modal-body">
						<p><b>Project Details</b><br/>
							This project was a join effort between School of Biomedical Sciences as directed by Associate Professor Peter Henry of the Division of Pharmacology, and Professional Computing Students of Years 2021 and 2018 at the University of Western Australia. Further web development work was undertaken in 2022 to improve the application prior to semester start.
							<br><br>
							
							<p><b>2022 Updates By:</b>
							<ul>
								<li><a href="https://www.kubawysocki.com">Jakub Wysocki</a></li>
								<li>Ehsan Noori</li>
							</ul></p> <br>
							</p>

						<p><b>2021 Team</b>
						<ul>
							<li>Jakub Wysocki</li>
							<li>Hannah Walkerden</li>
							<li>Ehsan Noori</li>
							<li>Lyulyu Su</li>
							<li>Ye Liu</li>
							<li>Stanley McFarlane</li>
						</ul>
						</p> <br>

						<p>
							<b>2018 Team</b>
						<ul>
							<li>Cameron Turner</li>
							<li>Daniel Brown</li>
							<li>Harry Brooker</li>
							<li>Thai Nguyen</li>
						</ul>
						</p><br>

						<b>Project Summary</b><br />
						Agonists produce effects in cells by activating receptors and downstream signalling pathways.
						This app contains an interactive “Dose Response Visualiser” which allows users to alter
						agonist-dependent factors (affinity, intrinsic efficacy) and/or cell-dependent factors (receptor
						density, signal amplification) and observe in real time how this changes the agonist
						dose-response relationship.<br />
						<br />Agonist-induced effects can be blocked by drugs called antagonists, which are amongst the
						most widely used class of drug in medicine. There exist many different types of antagonists,
						named on the basis of how they inhibit the agonist-induced effect: competitive, irreversible,
						allosteric and functional antagonists, and inverse agonists. Within the “Dose Response
						Visualiser”, users can observe the different patterns of effect produced by each of these
						antagonists (and the influence of antagonist concentrations and affinity) on the agonist
						dose-response relationship.<br />
						<br />Quantitative analysis of the effect of competitive antagonists on agonist-induced effects
						is a powerful method for identifying the receptors that mediate agonist-induced effects (Schild
						analysis), and is used in drug discovery and receptor characterisation. The app contains a
						“Schild Plot Generator”, where users can select the properties of agonists and antagonists and
						generate Schild Plots, and work through a series of theoretical questions and experimental
						scenarios that build proficiency and enhance understanding of key Schild concepts. The “Schild
						Plot Generator” also introduces users to a wide array of ‘non-ideal’ Schild Plots (e.g.
						nonlinear and/or slope different from unity), and moreover, provides users with information that
						can be used to identify and remedy the underlying causes of each form of ‘non-ideal’ Schild
						plot.<br />
						<br />These newly developed proficiencies and understandings can then be tested using the
						“Schild Analysis Quiz” tool within the app, were users are provided with a series of Schild
						Plots obtained to 5 antagonists acting on a single receptor subtype within a common cell, and
						users are challenged to analyse each of the Schild Plots using the SPIKES approach to deduce
						which single receptor subtype is mediating the agonist-induced response. Feedback is provided
						for each of the 1000s of different quiz questions.<br />
						<br />Additonally, there is access to various videos and detailed descriptions on non-ideal
						schild plots.<br />
						<br />Thus, SPIKESfunc is an interactive, educational application that boosts proficiency in the
						interpretation of functional pharmacological data through the visual and quantitative analysis
						of agonist and antagonist dose-response relationships. SPIKESfunc can be used in conjunction
						with SPIKESbind, a complementary interactive educational app designed to enhance proficiency in
						interpreting binding pharmacological data.<br />
						</p>
					</div>
					<div class="modal-footer">
						<button type="button" class="btn waves-effect waves-light red"
							data-dismiss="modal">Close</button>
					</div>
				</div>
			</div>
		</div>

		<div id="references" class="modal fade" role="dialog">
			<div class="modal-dialog">
				<div class="modal-content">
					<div class="modal-header">
						<h4 class="modal-title">About</h4>
					</div>
					<div class="modal-body">
						<p><b>References</b></p>
						<ul>
							<li> Berg KA, Clarke WP (2018) Making Sense of Pharmacology: Inverse Agonism and Functional
								Selectivity. Int J Neuropsychopharmacol. 21:962-977. </li></br>
							<li> Black JW, Leff P (1983) Operational models of pharmacological agonism. Proc R Soc Lond
								B Biol Sci. 220:141-62. </li></br>
							<li> Buchwald P (2020) A single unified model for fitting simple to complex receptor
								response data. Sci Rep. 10:13386. </li></br>
							<li> Buchwald P (2019) A Receptor Model With Binding Affinity, Activation Efficacy, and
								Signal Amplification Parameters for Complex Fractional Response Versus Occupancy Data.
								Front Pharmacol. 10:605.</li></br>
							<li> Buchwald P (2017) A three-parameter two-state model of receptor function that
								incorporates affinity, efficacy, and signal amplification. Pharmacol Res Perspect.
								5:e00311.</li></br>
							<li>Christopoulos A, Kenakin T (2002) G protein-coupled receptor allosterism and complexing.
								Pharmacol Rev. 54:323-74.</li></br>
							<li>Christopoulos A (2014) Advances in G protein-coupled receptor allostery: from function
								to structure. Mol Pharmacol. 86:463-78.</li></br>
							<li>Dougall IG, Unitt J (2015) Evaluation of the biological activity of compounds:
								techniques and mechanism of action studies. in The Practice of Medicinal Chemistry (4th
								Ed.), pp. 15-43. Edited by Wermuth CG, Aldous D, Raboisson P, Rognan D; Elsevier:
								London. </li></br>
							<li>Ehlert FJ (2015) Functional studies cast light on receptor states. Trends Pharmacol Sci.
								36:596-604.</li></br>
							<li>Gao ZG, Toti KS, Campbell R, Suresh R, Yang H, Jacobson KA (2020) Allosteric antagonism
								of the A2 adenosine receptor by a series of bitopic ligands. Cells 9:1200.</li></br>
							<li>Kenakin TP (1981) The Schild regression in the process of receptor classification. Can.
								J. Physiol. Pharmacol. 60:249-265.</li></br>
							<li>Kenakin T (2019) Analytical Pharmacology: How Numbers Can Guide Drug Discovery. ACS
								Pharmacol. Transl. Sci. 2:9−17.</li></br>
							<li>Kenakin T, Christopoulos A (2001) Analytical pharmacology: the impact of numbers on
								pharmacology. Trends Pharmacol Sci. 32:189-196.</li></br>
							<li>Kenakin TP, Beek D (1981) The measurement of antagonist potency and the importance of
								selective inhibition of agonist uptake process. J Pharmacol Exp Ther 219:112-120.</li>
							</br>
							<li>Kenakin TP (2019) A Pharmacology Primer: Techniques for more effective and strategic
								drug discovery. Fifth Edn. Elsevier Academic Press, San Diego, CA, USA.</li></br>
							<li>Kenakin TP (2006) Data-driven analysis in drug discovery. J Recept Signal Transduct Res
								26:299-327.</li></br>
							<li>Kenakin TP, Jenkinson S, Watson C. (2006) Determining the potency and molecular
								mechanism of action of insurmountable antagonists. J Pharmacol Exp Ther 319:710-23.</li>
							</br>
							<li>Kenakin TP, Watson C, Muniz-Medina V, Christopoulos A, Novick S. (2012) A simple method
								for quantifying functional selectivity and agonist bias. ACS Chem Neurosci 3:193-203.
							</li></br>
							<li>Kenakin TP (2017) A Scale of Agonism and Allosteric Modulation for Assessment of
								Selectivity, Bias, and Receptor Mutation. Mol Pharmacol 92:414-424.</li></br>
							<li>Keov P, Sexton PM, Christopoulos A (2011) Allosteric modulation of G protein-coupled
								receptors: a pharmacological perspective. Neuropharmacology 60:24-35.</li></br>
							<li>Langmead CJ, Fry VAH, Forbes IT, Branch CL, Christopoulos A, Wood MD, Herdon HJ (2006)
								Probing the Molecular Mechanism of Interaction between
								4-n-Butyl-1-[4-(2-methylphenyl)-4-oxo-1-butyl]-piperidine (AC-42) and the Muscarinic M1
								Receptor: Direct Pharmacological Evidence That AC-42 Is an Allosteric Agonist. Mol
								Pharmacol 69:236-246.</li></br>
							<li>Leff P, Martin GR, Morse JM. (1985) Application of the operational model of agonism to
								establish conditions when functional antagonism may be used to estimate agonist
								dissociation constants. Br J Pharmacol 85:655-63.</li></br>
							<li>Lew MJ (1995) Extended concentration-response curves used to reflect full agonist
								efficacies and receptor occupancy-response coupling ranges. Br J Pharmacol 115:745-52.
							</li></br>
							<li>Neubig RR, Spedding M, Kenakin T, Christopoulos A (2003) International Union of
								Pharmacology Committee on Receptor Nomenclature and Drug Classification. International
								Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification.
								XXXVIII. Update on terms and symbols in quantitative pharmacology. Pharmacol Rev
								55:597-606.</li></br>
							<li>Offermeier J, van den Brink FG (1974) The antagonism between cholinomimetic agonists and
								beta-adrenoceptor stimulants. The differentiation between functional and metaffinoid
								antagonism. Eur J Pharmacol 27:206-13.</li></br>
							<li>Van den Brink FG (1973) The model of functional interaction. I. Development and first
								check of a new model of functional synergism and antagonism. Eur J Pharmacol 22:270-8.
							</li></br>
							<li>Van den Brink FG (1973) The model of functional interaction. II. Experimental
								verification of a new model: the antagonism of beta-adrenoceptor stimulants and other
								agonists. Eur J Pharmacol. 22(3):279-86.</li></br>
							<li>Wyllie DJ, Chen PE (2007) Taking the time to study competitive antagonism. Br J
								Pharmacol 150:541-51.</li></br>
							<li>Zhao P, Furness SGB (2019) The nature of efficacy at G protein-coupled receptors.
								Biochem Pharmacol 170:113647.</li></br>
						</ul>
					</div>
					<div class="modal-footer">
						<button type="button" class="btn waves-effect waves-light red"
							data-dismiss="modal">Close</button>
					</div>
				</div>
			</div>
		</div>


		<div id="instructions" class="modal fade" role="dialog">
			<div class="modal-dialog modal-lg">
				<div class="modal-content">
					<div class="modal-header">
						<h4 class="modal-title">Instructions</h4>
					</div>
					<div class="modal-body">
						<ul class="nav nav-tabs nav-pills nav-justified" role="tablist">
							<li class="nav-item">
								<a class="nav-link active" data-toggle="tab" href="#qual">Dose-Response
									Visualiser</br></a>
							</li>
							<li class="nav-item">
								<a class="nav-link" data-toggle="tab" href="#quant">Schild Plot Generator</a>
							</li>
							<li class="nav-item">
								<a class="nav-link" data-toggle="tab" href="#quizz">Schild Plot Analysis Quiz</a>
							</li>
						</ul>
					</div>
					<div class="tab-content">
						<div id="qual" class="container tab-pane active">
							<div class="col col-lg-12">
								<p><span style="color:Red">Agonists</span> bind to and activate receptors to induce
									changes in the activity of the receptor-expressing
									cells – a simple schematic of this process, together with a short animation, can be
									seen by clicking the <span style="color:red">red <span
											class="fa fa-info-circle"></span> Agonist</span> icon. The
									magnitude of these agonist-induced changes in cell activity are dependent on the
									concentration of
									the agonist, and are typically displayed using agonist dose-response curves (see
									default sigmoid-
									shaped Agonist Dose-Response Curve).
								</p>
								<p>
									Agonist dose response curves provide important information regarding:
								</p>
								<p>
									<b>1.</b> The maximum level of effect (response) induced by the highest
									concentrations of agonist
									(expressed as a percentage of the maximum change in cell activity, %Emax), and
								</p>
								<p>
									<b>2.</b> The potency of the agonist, which is the concentration of the agonist
									producing a particular level
									of effect (response), usually expressed as the molar concentration of agonist
									producing 50% of the
									agonist’s maximum response (EC<sub>50</sub> value).
								</p>
								<p>
									The shape and position of agonist dose-response curves depend upon the properties of
									both the
									agonist (affinity and intrinsic efficacy) and the cell (receptor density and the
									signal amplification).
									Specific information about these parameters can be obtained by clicking the <span
										style="color:red">red <span class="fa fa-info-circle"></span> icons</span>.
								</p>
								<p>
									Relative values for the four agonist and cell parameters are represented by the red
									sliders, and can be
									changed by moving the sliders to the left (to decrease parameter value) or to the
									right (to increase
									parameter value) along the grey bar. Thus, this agonist dose-response visualiser
									enables you to
									visualise how the position and shape of the agonist dose-response curve changes in
									response to
									increases or decreases in agonist affinity or efficacy or in cell receptor density
									or signal amplification.
								</p>
								<p>
									You can enhance your understanding of these key concepts of agonism by working
									through a series
									of Questions (see Questions window) that encourage the use of the Dose-Response
									Visualiser (see
									the ‘Question’ window). An Answer to each of the Questions posed can be obtained by
									clicking on
									the Reveal Answer icon.
								</p>
								<p>
									<span style="color:red">Antagonists</span> bind to receptors and inhibit
									agonist-induced responses. There exist different classes of
									antagonists, including Competitive antagonists, Irreversible antagonists, Allosteric
									antagonists,
									Functional antagonists and Inverse Agonists. As their names suggest, these different
									classes of antagonist interact with
									the receptors in distinct ways, and likewise affect agonist dose-response curves in
									characteristic
									ways – thus each class of antagonist has its own visualiser. Further information
									about each of these
									classes of antagonists can be obtained by clicking the <span style="color:red">red
										<span class="fa fa-info-circle"></span> Antagonist</span> icon in each specific
									window, to reveal a mechanistic overview and a short animation.
									The magnitude of inhibitory effects produced by an antagonist depends upon both the
									concentration and affinity of the antagonist. By default, the effects produced by 1,
									10, 100 and 1000
									nM concentrations of antagonist on the agonist dose-response curves are displayed in
									red. These default
									concentrations of antagonist can be individually altered by clicking on the up/down
									chevrons in the Table
									located below the dose-response curves. The effect of changing the affinity of the
									antagonist on these effects
									can also be visualised by moving the red sliders in the Antagonist window to the
									left (to decrease antagonist affinity) or to the right
									(to increase antagonist affinity) along the grey bar. The extent to which the
									actions of the antagonist
									is dependent on the characteristics of the agonist (affinity, intrinsic efficacy)
									and/or cell (receptor
									density, signal amplification) can also be displayed by moving the appropriate
									sliders in the Agonist or
									Cell windows.
								</p>
								<p>
									A return to default parameter values can be accomplished by clicking on the
									<b>RESET</b> button.
								</p>
								<p>
									You can enhance your understanding of these key concepts of antagonism by working
									through a
									series of Questions (see Questions window) that encourage the use of the
									Dose-Response Visualiser
									(see the ‘Question’ window). An Answer to each of the Questions posed can be
									obtained by clicking
									on the Reveal Answer icon.
								</p>
								<p>
									Users can learn more about the concepts of Agonism and Antagonism by watching
									animations,
									a complete library of which can be found within the video tab.
								</p>
							</div>
						</div>
						<div id="quant" class="container tab-pane">
							<div class="col col-lg-12">
								<p>
									Schild analyses enable the determination of the affinity (K<sub>B</sub>) of a
									competitive antagonist at a
									particular receptor that is mediating the response produced by an agonist. Thus, the
									Schild analysis
									is a particularly powerful approach for classifying and identifying the functional
									roles played by
									various receptor subtypes.
								</p>
								<b>How to create a Schild Plot:</b></br>

								<div style='text-align:center'>
									<video width="320" height="240" controls>
										<source src="images\How to create a Schild plot.mp4" type="video/mp4">
									</video>
								</div>

								<br>
								<p>
									As shown in the Dose-Response Visualiser, competitive antagonists produce a
									parallel, rightward
									shift of the agonist dose-response curve with no reduction in the maximum
									agonist-induced effect.
									The magnitude of the rightward shift increases as the [competitive antagonist]
									increases, and the
									magnitude of the shift (Dose Ratio) can be used to measure the affinity of the
									competitive
									antagonist for the receptor (Schild analysis). The Schild Plot plots the
									–log[antagonist] (M) on the x-
									axis against the calculated log(DR-1) on the y-axis (as can be seen in the Schild
									Plot window).
								</p>
								<p>
									If certain conditions are met (plot is linear with a slope of 1.0), then a Schild
									Plot can be used to generate a
									pA<sub>2</sub> value, which is an estimate of the affinity of the competitive
									antagonist (K<sub>B</sub> value) for the
									receptor through which the agonist is producing the response. The pA<sub>2</sub> is
									determined by measuring
									the value of the dose ratio (DR) at several antagonist concentrations, allowing an
									estimate of the
									antagonist concentration at which log(DR-1) is zero.
								</p>
								<p>
									The calculated –logK<sub>B</sub> value of the antagonist can then be compared to
									known –logK<sub>i</sub> values of the
									antagonist obtained from the binding of the antagonist to pure populations of
									receptor subtypes,
									and through a process of elimination (incorporating the SPIKES approach), the
									receptor mediating
									the agonist-induced response identified.
								</p>
								<p>
									<b><i>In the Schild Plot Generator</i></b> you can choose the characteristics of the
									agonist (affinity, intrinsic
									efficacy) and cell (receptor density, signal amplification) by moving the red
									sliders along the grey
									bar (as per Dose-Response Visualiser). Furthermore, you can select the
									characteristics of the antagonist
									(e.g. affinity in the Competitive Antagonist window) and select up to four
									[antagonist] (in the Schild Plot Analysis
									window) for use in the Schild Analysis, by entering specific values or by using the
									up/down chevrons.
									The Schild Plot Generator determines the [Agonist] that produces 50%Emax for each
									agonist dose-
									response curve to calculate the dose ratio and log(DR-1) values, which are presented
									within the
									Schild Analysis Table. The log(DR-1) values for the 4 [antagonist] are then plotted
									to generate the
									idealised Schild Plot. Any of the agonist, cell of antagonist parameters can be
									changed at any time
									and the effect on the Schild plot shown in real time. A return to default parameter
									values can be
									accomplished by clicking on the <b>RESET</b> button.
								</p>
								<p>
									You can enhance your understanding of the key concepts surrounding the theoretical
									and practical
									aspects of Schild Analysis by working through a series of Questions (see Questions
									window) that
									encourage the use of the Schild Plot Generator and the Reference Table of
									‘-logK<sub>i</sub> values’. An Answer
									to each of the Questions posed can be obtained by clicking on the Reveal Answer
									icon. Completing these
									questions, together with an understanding of the SPIKES approach to interpreting
									Schild plot data,
									will prepare you well for the ‘Schild Plot Analysis Quiz’.
								</p>
								<p>
									The first (default) page you will see in the Schild Plot Generator is the “Schild
									Plot Generator for Competitive
									Antagonist”. In addition, you can also investigate how non-competitive antagonists,
									such as irreversible,
									allosteric and functional antagonists produce Schild Plots that are typically
									nonlinear and/or have a slope
									not equal to 1.0. You will notice that the different types of antagonist produce
									quite distinct types of
									Schild Plot. For example, whereas irreversible antagonists always produce Schild
									plots with a slope > 1.0,
									allosteric antagonists will generally produce Schild Plots with a slope < 1.0. The
										inclusion of these non-competitive antagonists in the Schild plot generator is
										primarily for illustrative purposes, and not to suggest that such non-ideal
										Schild plots can be used to generate legitimate –logK<sub>B</sub>
										values from the pA<sub>2</sub> value.
								</p>
								<p>
									Although Schild Plots for competitive antagonists should be linear with a slope not
									significantly different
									from 1.0 (ideal), there are many instances in the published scientific literature of
									‘non-ideal’ Schild Plots,
									where the plot is nonlinear or has a slope different from 1.0. ‘Non-ideal’ Schild
									Plots to competitive
									antagonists typically reflect non-ideal experimental conditions. In the “Schild Plot
									Generator”, the
									‘Non-Ideal Schild Plot’ page provides illustrations of some of the ways that Schild
									Plots can deviate
									from being ideal (e.g. nonlinear with a slope < 1.0 at low concentrations of the
										antagonist), while also providing mechanistic insights and potential remedies.
										</p>
										<p>
											Users can learn more about Schild plots by watching animations,
											a complete library of which can be found within the video tab.
										</p>
							</div>
						</div>
						<div id="quizz" class="container tab-pane">
							<div class="col col-lg-12">
								<p>
									The ‘Schild Plot Analysis Quiz’ presents you with a series of Schild Plots obtained
									to 5 antagonists
									acting on a single receptor subtype within a common cell. The challenge is to
									analyse each of the
									Schild Plots to deduce which single receptor subtype is mediating the
									agonist-induced response.
								</p>
								<p>
									A key factor in determining which receptor subtype is mediating the response is the
									application of
									the SPIKES approach. SPIKES is a mnemonic that provides a stepwise approach for
									analysing Schild
									plots.
								</p>

								<b>SPIKES Approach 1:</b><br>

								<div style='text-align:center'>
									<video width="320" height="240" controls>
										<source src="images/Initial steps in SPIKES approach.mp4" type="video/mp4">
									</video>
								</div>

								<br>
								<p>
									<span style="color:red; font-size: 22px"><b>S</b></span>hape of the Schild Plot –
									should be linear. Nonlinearity is indicative of key assumptions of the
									Schild Analysis not being met (e.g. antagonism must be competitive) and makes the
									pA<sub>2</sub> values
									potentially unreliable for K<sub>B</sub> determination. In the Quiz, analyse the
									shape of each Schild plot and
									select from the drop-down options (linear, nonlinear up, nonlinear down) the most
									appropriate
									description of the shape of the Schild Plot.
								</p>
								<p>
									<span style="color:red; font-size: 22px"><b>P</b></span>osition of the Schild Plot
									provides the pA<sub>2</sub> value – i.e. x-axis intercept. If the pA<sub>2</sub> is
									derived from a
									linear Schild plot with slope not significantly different from 1.0, then it can be
									converted to K<sub>B</sub> and be
									a true measure of the affinity of the antagonist for the receptor mediating the
									agonist-induced
									response. In the Quiz, enter the numerical value of the pA<sub>2</sub> for each
									antagonist.
								</p>
								<p>
									<span style="color:red; font-size: 22px"><b>I</b></span>nclination of the Schild
									Plot = slope of the Schild Plot, and should not be significantly different from
									value of 1.0. If slope &lt; 1, pA<sub>2</sub> is over-estimated &amp; if slope &gt;
									1, then pA<sub>2</sub> value is under-estimated. In
									the Quiz, determine the slope and select from the drop-down options (Slope=1,
									Slope&lt;1, Slope&gt;1,
									unsure) the most appropriate description of the slope for each antagonist Schild
									Plot.
								</p>
								<p>
									<span style="color:red; font-size: 22px"><b>K</b></span><sub>B</sub> is the antilog
									of the pA<sub>2</sub> and is a direct measure of the affinity of the antagonist for
									the receptor
									mediating the agonist-induce response. The K<sub>B</sub> value can be reliably
									derived from pA<sub>2</sub> only if the
									Schild plot is linear with unit slope. In the Quiz, determine whether the
									K<sub>B</sub> value can be reliably
									obtained from the pA<sub>2</sub> value (based on the prior analysis of Shape
									(linear) and Inclination (slope=1)
									of each Schild plot) by selecting the appropriate response from the drop-down list
									(Yes, No, Unsure).
								</p>

								<b>SPIKES Approach 2:</b><br>

								<div style='text-align:center'>
									<video width="320" height="240" controls>
										<source src="images/Elimination and summation in SPIKES.mp4" type="video/mp4">
									</video>
								</div>

								<br>
								<p>
									<span style="color:red; font-size: 22px"><b>E</b></span>limination. If for any
									antagonist, there is at least a 1.0 log unit difference between the observed
									pA<sub>2</sub> value and the known –logK<sub>i</sub> value at any particular
									receptor subtype (see reference Table of
									–logK<sub>i</sub> values), then that receptor subtype is unlikely to have mediated
									the agonist-induced response
									and can be eliminated from further analysis. In the Quiz, for each antagonist check
									the receptor box
									to indicate that that receptor has been eliminated.
								</p>
								<p>
									<span style="color:red; font-size: 22px"><b>S</b></span>ummation. In the Elimination
									process, each different antagonist is likely to have been able to
									eliminate one or more receptor subtypes as having mediated the agonist-induced
									response. By using
									the information obtained by using ALL the antagonists, a concerted process of
									elimination should
									leave just one receptor subtype as having mediated the response induced by the
									agonist. All
									obtained pA<sub>2</sub> values should be close to the –logK<sub>i</sub> values for
									the sole non-eliminated receptor. In the
									Quiz, in the ‘Your Solution’ window select the sole receptor subtype that is
									mediating the response.
								</p>
								<p>
									An additional feature of the Quiz is the inclusion of a hypothetical antagonist
									called Ant3311.
									The Schild plot for Ant3311 will not satisfy the requirements of linearity and/or
									unity of slope.
									In the Quiz, based on your analysis of the Ant3311 Schild plot and your
									understanding of why Schild
									plots may be nonlinear and/or have an slope different from 1.0 (as outlined in the
									Schild Plot
									Generator), enter the most appropriate description of why Ant3311 Schild Plot is not
									ideal from the
									drop-down options (‘Ant3311 is an allosteric antagonist at this receptor’, ‘Ant3311
									is an irreversible
									antagonist at this receptor’, ‘Ant3311 is toxic to cells at high concentrations’,
									‘Ant3311 is a
									substrate of a saturable uptake process’). To submit all your answers, click on the
									‘Submit Answers’
									button. This will take you to a new page that will indicate whether your submitted
									Answers were
									correct or incorrect. If your answers are correct, then you will receive affirmation
									of this,
									and have the option of starting a ‘New Quiz’.
								</p>
								<p>
									If either of your answers is incorrect, then you will receive immediate feedback –
									both the selected and correct answers will be presented side-by-side in visual form,
									with explanations.
									You then have the opportunity to ‘learn more’ (by visiting the Schild Plot Generator
									pages), ‘amend your
									answers’ or to start a ‘new quiz’ by clicking the appropriate button.
								</p>
								<p>
									<b>Assumptions made in the Schild Plot Analysis Quiz</b><br>
									<b>1. Linearity is assessed by visual inspection.</b> As indicated in the video
									above (SPIKES approach 1),
									determining that a Schild plot is linear requires statistical testing (e.g. Analysis
									of Covariance)
									of many replicates of the Schild plot that have been obtained experimentally. For
									the purposes of the
									Schild Plot Analysis Quiz, linearity is confirmed by visual inspection – presented
									Schild Plots will
									either be linear or obviously nonlinear.<br>
									<b>2. Inclination (slope) is assessed by visual inspection.</b> As indicated in the
									video above (SPIKES approach 1),
									determining that a Schild plot has a slope that is not different from 1.0 requires
									statistical testing
									(e.g. use of 95% confidence intervals) of many replicates of the Schild plot that
									have been obtained
									experimentally. For the purposes of the Schild Plot Analysis Quiz, slope is
									confirmed by visual
									inspection – presented Schild Plots will either have a slope that 1.0 or a slope
									that is obviously
									different from 1.0.<br>
									<b>3. Elimination is based on a difference of at least 1.0 between –logKB value and
										–logKi values.</b>
									As indicated in the video above (SPIKES approach 2), the elimination process is
									based on the known –logKi
									values laying outside the 95% confidence intervals of the–logKB value of the
									antagonist determined using
									many replicates of the Schild plot that have been obtained experimentally. For the
									purposes of the Schild
									Plot Analysis Quiz, a –logKi values is assumed to be different from a –logKB value
									if there is a difference
									of 1.0 log unit of more.
								</p>
							</div>
						</div>
					</div>
					<div class="modal-footer">
						<button type="button" class="btn waves-effect waves-light red"
							data-dismiss="modal">Close</button>
					</div>
				</div>
			</div>
		</div>
		<div id="contact" class="modal fade" role="dialog">
			<div class="modal-dialog">
				<div class="modal-content">
					<div class="modal-header">
						<h4 class="modal-title">Contact</h4>
					</div>
					<div class="modal-body">
						<p>Is something not working properly?<br />Have an idea about how can we improve the interactive
							tools?<br />Please
							contact us!</p>
						<div class="box">
							<p class="contact"><b>Liz Johnstone</b><br />Lecturer<br />The University of Western
								Australia</p>
							<p class="contact"><a
									href="mailto:liz.johnstone@uwa.edu.au?Subject=SPIKESfunc%20feedback">liz.johnstone@uwa.edu.au</a>
							</p>
							<p class="contact"><b>Peter Henry</b><br />Associate Professor<br />The University of
								Western Australia</p>
							<p class="contact"><a
									href="mailto:peter.henry@uwa.edu.au?Subject=SPIKESfunc%20feedback">peter.henry@uwa.edu.au</a>
							</p>

						</div>
					</div>
					<div class="modal-footer">
						<button type="button" class="btn waves-effect waves-light red"
							data-dismiss="modal">Close</button>
					</div>
				</div>
			</div>
		</div>
	</footer>
</body>

</html>